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AIMS AND OBJECTIVES 
1. Review data of all patients with vertigo to assess the frequency of   migrainous 
Vertigo among patients attending the Audio vestibular clinic of CMC over a  6 month 
period prior to start of a prospective evaluation. 
 
2. Determine the frequency of auditory dysfunction among patients with migrainous 
vertigo compared to the normal. 
 
3. Evaluate the auditory status of patients with migrainous vertigo   
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
  INTRODUCTION 
 
Migrainous vertigo is a vestibular syndrome which is caused by migraine and is characterised 
by short spells of spontaneous or positional vertigo which can lasts from only a few seconds 
to weeks. There are no established diagnostic criteria for migrainous vertigo as it is not 
included presently in the International Headache Society classification of migraine (1).  
Neuhauser (1) however proposed a diagnostic criterion for the entity and that has been widely 
accepted. 
Migrainous vertigo was a poorly known entity till 1980s. Migrainous vertigo associated with 
problems in auditory pathway is even less well-known or documented. There are only a few 
numbers of studies addressing this issue (1, 2, and 3).  Migraine and migrainous vertigo are 
considered to be a result of chemical abnormalities in the Serotonin pathway (7). 
 
 
Approximately 33% of patients with migraine present with complains of vertigo (1, 2). , 
Patients with migraine can also present with auditory complaints like tinnitus, aural fullness, 
decreased hearing and phonophobia (1,2). There are reports of sudden, permanent  and 
fluctuating hearing loss associated with migraine However,  the incidence of hearing loss in 
migraine is low(1,3,4). 
Just as migrainous vertigo lacks an established diagnostic criterion, the pathophysiological 
mechanisms and treatment strategies continue to be elusive. Various pathophysiological 
mechanisms have been proposed. Migrainous vertigo can present as a migraine aura or a 
longer lasting vestibular syndrome. 
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Cortical and brainstem spreading depression occurs as a result of glial and neuronal 
depolarisation occurring at cortical and brainstem levels and is regarded as the mechanism of 
migraine aura (5,6). 
The longer lasting vestibular symptoms can be attributed to the activity of the 
trigeminovascular system causing release of various inflammatory neuropeptides into the 
dural circulation during headache (7) 
Migrainous vertigo is essentially a diagnosis of exclusion.  Physical examination is likely to 
be normal.  
History however will usually provide the clue to the diagnosis than tests. Various 
investigations that could be done include imaging, otoacoustic emissions,  auditory brain 
stem evoked response and audiometry in order to exclude other pathological conditions. 
Studies have shown that the interpeak and absolute latencies during brainstem evoked 
response testing could be prolonged in migrainous vertigo.(8) Thus abnormalities of the 
auditory brainstem response testing may be the earliest indicator of impending auditory 
involvement in migraine (8). 
Migraine has increased incidence in Meneire’s disease and benign paroxysmal positional 
vertigo. 
There have been reports of sudden sensory neural hearing loss with acute attacks of migraine 
(1, 2).  Early preventive treatment would result in avoiding the morbidity caused by both 
these conditions like vertigo, and headaches which could often be incapacitating. It may also 
help to avoid the effects on hearing if the same chemical pathway is affecting the auditory 
pathway. Hence this study is preliminary and is intended to determine the frequency of 
migrainous vertigo and to investigate the involvement of auditory pathway among patients 
with migrainous vertigo. 
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 REVIEW OF LITERATURE 
 
ANATOMY OF INNER EAR 
The inner ear consists of the cochlea, vestibule and the semicircular canal. The cochlea can 
be compared to a snail as it is a canal which spirals around itself and makes about 2 ½ to 2 ¾ 
turns. The labyrinth is of two types namely the membranous labyrinth filled with the 
endolymph and the bony labyrinth which surrounds the membranous labyrinth which is filled 
with perilymph.  
The cochlea is divided into an upper chamber called the scala vestibule, filled with 
perilymph, and a lower chamber called the scala tympani, also filled with perilymph 
separated by a middle chamber called scala media or the cochlear duct filled with endolymph. 
The scala media is separated from the scala vestibule by the Reissner’s membrane and the 
media from the scala tympani by the basilar membrane. 
On the floor of the basilar membrane is situated the organ of Corti which is the receptor 
organ of the inner ear and has a single row of inner hair cells situated medially and three to 
four rows of outer hair cells laterally on either sides of the rod or tunnel of Corti. 
On the medial aspect of the scala media there is a tectorial membrane which is a fibrous 
structure and it comes in contact with the stereo cilia of the hair cells .The bipolar cells of 
spiral ganglion situated in the Rosenthal’s canal have dendrites which synapse with the base 
of the hair cells (9). 
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Auditory pathways 
The cochlear division of the auditory nerve is formed by the axons of the bipolar cells and 
end in the cochlear nuclei, both dorsal and ventral on either side of the medulla. From the 
cochlear nuclei, crossed and uncrossed fibres travel to the superior olivary nucleus, lateral 
leminiscus, inferior colliculus and the medial geniculate body and finally reach the auditory 
cortex of the temporal lobe. The central auditory pathway is from the cochlear nuclei to the 
auditory cortex in the temporal lobe. Impulses reach the auditory cortex via a four neuron 
pathway. There are both first order and second order neurons, the first order being the bipolar 
neurons which connect the hair cells to the cochlear nuclei. The afferent to the cochlear 
nuclei is always from the ipsilateral cochlea and auditory nerve. 
The second order neurons start from the cochlear nuclei and project to the contra lateral 
inferior colliculus. 
The axons of these neurons decussate in the trapezoid body or synapses with neurons in the 
superior  olivary nucleus. Both ipsilateral and contralateral   afferent axons from the cochlear 
nuclei are received by superior olivary complex on both sides. 
Neurons from the superior olivary nucleus pass to the lateral leminiscus of the midbrain. The 
third order neurons connect the inferior colliculus to the medial geniculate body. The fourth 
order neurons connect the medial geniculate body to the cerebral cortex. 
The auditory cortex in the temporal lobe, known as the Brodman’s area 41 and 42 is the gyrus 
of Heschl on the upper part of the superior temporal gyrus in the sylvian fissure. Clinically 
these areas are important as they control the visual and somaesthetic aspects of language (10). 
Physiology of hearing 
The ear is the sensory organ which gathers acoustic or sound energy and converts it into 
neural or electrical stimuli and this neural stimulus is further transmitted to the brain for 
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processing. The pinna and the external auditory canal capture the sound waves and direct it to 
the tympanic membrane causing it to vibrate. 
These vibrations are transmitted to the ossicles of the middle ear and through them to the 
perilymph of the inner ear forming a fluid wave. The impedance matching mechanism of the 
middle ear compensates for about 30 decibels loss of acoustic energy. The middle ear 
converts sound energy of greater amplitude and lesser force into greater force and lesser 
amplitude.  
The sensory organ of hearing, the organ of Corti has both outer and inner hair cells. The inner 
hair cells pick   up the vibrations of the basilar membrane and convert them into impulses for 
the auditory nerve. The functions of outer hair cells are, 
1. Participate in the micromechanics of the cochlea by amplifying the motion of the 
basilar membrane. 
2. Adds approximately 50 decibels to the sensitivity of the cochlea  
3. Increases the frequency selectivity of the cochlea for low intensity sounds, thus 
improving the ability to detect soft sounds in noisy environments. 
However, the outer hair cells do not have any role in the transmission of electrical impulses 
which is done by the inner hair cells. Each point on the basilar membrane is tuned to a 
specific frequency. Different groups of hair cells are activated by sounds of varying 
frequencies within the spectrum of audibility and different inner hair cells are tuned to 
different frequencies (11). 
There are  five well studied electro acoustic events in the cochlea which are, 
1. Endocochlear potential-positive voltage of 80-100 millivolts seen in the 
endolymphatic space of cochlea 
2. Cochlear microphonics-is an alternating potential and is a true reflection of the 
electrical activity of the outer and inner hair cells. 
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3. The Summating potentials-which is a direct current offset  and part of cochlear 
microphonics 
4. The compound action potential-which is the sum of synchronous discharges  in 
response to a click or transient stimulus. It is this action potential which forms the 
wave 1 of the brain stem evoked response auditory. 
      5.    Otoacoustic emissions-are acoustic outputs from the outer hair cells as a result of   
both mechanical distortion products and direct echoes. (12) 
 
  
 
MIGRAINOUS VERTIGO 
Migrainous vertigo (MV) is defined as vertigo or dizziness caused by migraine. 
Approximately 10% of the population has migraine headaches (13) and one third of persons 
with migraine experience dizziness (14) so the prevalence of MV can be estimated as 
approximately 3% of the population.  
Currently, there is no unifying term or internationally approved criterion for migraine 
associated vertigo. Without such criteria, determination of the pathophysiology and 
appropriate treatment regimens for these patients will continue to be elusive. 
HISTORICAL BACKGROUND 
The association between hearing and balance disorders and migraine has been recognized 
since ancient Greece, when in 131 B.C. Aretaeus of Cappadocia described precisely and in 
detail the occurrence of both conditions during a migraine crisis (15). In 1861, Prosper 
Ménière published a classical paper describing the symptoms of Ménière Syndrome (MS) in 
migraine patients (16). In 1873, Liveing reported a clear association between vertigo and 
migraine, which has since been also reported by various authors in various other studies and 
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these studies defined the concept that vertigo, hearing loss and tinnitus were part of the 
symptoms that some migraine patients presented(17,18). 
The manifestations of migrainous vertigo were studied and published in various case series 
beginning from Kayan and Hood’s publication (18). The disease lacks a generally accepted 
diagnostic criterion and a proper terminology as it is only an evolving entity and the 
pathophysiology and treatment are still under research. Various terminologies have been put 
forth namely migraine associated vertigo, vestibular migraine, migraine associated dizziness, 
migrainous vertigo, benign recurrent vertigo and migraine associated vestibulopathy. 
Vestibular migraine has been increasingly used as the terminology these days as this stresses 
more on the vestibular symptoms of the disease. The link between vertigo and migraine were 
promoted by various epidemiological associations. 
 Many of the dizziness patients have migraine and conversely, many migraine patients report 
dizziness as a symptom (18, 19). The lifetime prevalence of migraine in the general 
population was found to be 14% (20) and that of vertigo 7% (3); migraine and vertigo 
together was found to be 3.2 % (21) in a large population based study.  
EPIDEMIOLOGY 
In three large population based studies the lifetime prevalence of migraine in the general 
population was found to be 14% (20) and that of vertigo 7% (3) and that of migraine and 
vertigo together was found to be 3.2 % (21). In the United States the prevalence rates of 
migraine ranges from 16-18% in women and 4-6% in men (22). In a study at a dizziness 
clinic in the United states with 200 patients, the prevalence of migraine was 38% and that of 
migrainous vertigo was 7% (19). 
In a German population survey (3), 1212 out of 4077 patients (24%) who were interviewed 
telephonically had experienced vertigo in their lifetime. Out of 1003 patients who completed 
the interviews 243(24%) experienced vertigo due to migraine and out of the  24%, 40% 
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experienced spontaneous rotational vertigo, 43% positional vertigo and 17% episodic nausea 
with oscillopsia or imbalance(3). Detailed study of this sample showed 3.2% of these patients 
with of Migrainous vertigo. In a study by Kayan and Hood of 200 migraine patients in the 
United Kingdom, 27%   had experienced vertigo (18).  
 
 DIAGNOSTIC CRITERIA 
Neuhauser et al. in 2001 published ‘‘The Interrelations of Migraine, Vertigo, and Migrainous 
Vertigo’’ in order to provide an acceptable diagnostic criteria for migraine-associated vertigo 
(19).They made a criterion for definite as well as for probable migrainous vertigo. Probable 
migrainous vertigo is similar to definite migrainous vertigo though a less specific but more 
sensitive entity. This entity was created for individuals who could not be strictly diagnosed as 
migrainous vertigo, but still appeared to be most likely, migrainous vertigo. With the help of 
this criterion, they were able to delineate a statistically significant association between 
vertigo and migrainous headaches, with 38% of vertigo patients having migraines compared 
with only 24% of controls (19). 
Radke et al in a recent study in 2011 checked the validity of the diagnostic criterion given by 
Neuhauser and colleagues. He and has colleagues conducted a long-term follow-up of those 
diagnosed with definite or probable migrainous vertigo (23).He followed up the patients for a 
mean period of 8.75 years, the minimum being 5.4 years and maximum being 11 years and 
found out that 85% of patients as diagnosed with migrainous vertigo, were having the 
disease, thus the positive predictive value was 85%. 50 % of patients with probable 
migrainous vertigo were later, on follow up diagnosed to have definite migrainous vertigo 
and 32% had only probable migrainous vertigo. With the onset of hearing loss in some 
patients, some of the diagnosed patients of migrainous vertigo were reclassified as Meniere’s 
disease. Patients with migrainous vertigo had migrainous headache with aura and the 
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percentage was shown to be 63%.However, only 22% of patients with probable migrainous 
vertigo had migraine with aura. The criterion given by Radke et al was precise in the long 
term, had doubts on its diagnostic precision. The criterion given was; 
 1) Rotational vertigo-at least three attacks which were spontaneous 
 2) Duration of episode at least a minute  
3) No associated one sided decreased hearing.  
Radke et al conducted telephone interviews with patients suffering from recurrent vertigo 
which was benign and  who had migraine as well .Among these patients they found that 87% 
had imbalance ,and 92% had nausea. Headache was present in only 50% of them. They 
proposed that diagnosis should be based on the pathophysiology rather than clinical features. 
Another study by Brantberg et al., there was a suggestion that there were different forms of 
migrainous vertigo which were likely to be present, however research is still going on to 
probably show the differences between the different types of the disease (24). 
In another recent study, Cohen et al. in 2011 did a review of chart of patients diagnosed with 
migrainous vertigo retrospectively to study the disease further and understand the patho 
physiology. Their diagnostic criteria were patients with: 
1) Migrainous headache  according to the International headache society classification  and  
2) One symptom of migrainous vertigo with at least one vestibular trigger. The most common 
vestibular symptoms according to their study were light headedness, unsteadiness and 
balance disorders. Various triggers for the disease were documented like crowds, moving 
objects and flashing lights. In their study the vestibular symptoms like vertigo were more 
likely to be associated with migrainous headache with aura than without aura. They also 
suggested that if the common features of migrainous vertigo can be crafted together, an 
acceptable diagnostic criteria can be made, although in this study, no definite criteria was 
made as the data was not sufficient enough.(25). 
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. In another study by Reploeg and Goebel in 2002, an analysis of patients retrospectively was 
conducted to investigate the efficacy of treating migraine and thus reducing the dizziness 
associated with it. In this study the Patients in whom a diagnosis of migrainous vertigo was 
made, the treatment was given with anti migraine drugs and their response was detected. 
They did not have a specific diagnostic criterion for migraine. The patients were followed up 
for a mean period of 54.5 weeks and 72% of the patients had more than 75% reduction in 
headache and all patients except 4 of them had reduction in their dizzy spells. The clinical 
response to treatment thus can be used to validate the diagnostic criteria, although the 
diagnostic criterion was not specified. Thus as finding acceptable treatment options are the 
final culmination of the controversies research continues to determine the pathophysiology of 
migrainous. (26). 
In any disease, the pathophysiology of the condition will dictate the diagnosis and treatment. 
But when the pathophysiology of any disease is not fully understood, the diagnostic criteria 
will have to be substantiated by its treatment outcomes. Studies are still going on to 
investigate migrainous vertigo, and there no gold standard diagnostic criterion for it. 
However, Neuhauser et al’s criteria (19) presents a broad based starting point in  guiding 
health care workers diagnosing and treating this relatively increasingly  recognized entity. 
 
 
 
Diagnostic Criteria for Migrainous Vertigo (19) 
Definite MV   
1) Vestibular symptoms of at least moderate severity which are episodic (rotational vertigo, 
positional vertigo, head motion intolerance which is a sensation of imbalance or object 
motion that is provoked by head motion). At least one of the following migrainous symptoms 
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during at least two attacks of vertigo: migrainous headache, increased sensitivity to lights, 
increased sensitivity to sounds, visual or other auras. 
2) Migrainous headaches according to the International Headache Society criteria (IHS). 
3) Other causes of vertigo ruled out by investigations. 
 Probable MV 
1) Vestibular symptoms which are episodic of at least moderate severity (rotational vertigo, 
other illusory self or object motion, positional vertigo, head motion intolerance).  
2) At least one of the following: migrainous headaches according to the criteria of the IHS; 
migrainous symptoms during vertigo; migraine triggers of vertigo, (e.g. hormonal changes, 
sleep irregularities, specific foods); or response to anti migraine drugs. 
3) Other causes of vertigo ruled out by investigations. 
 
The International Classification of Headache Disorders, 2nd Edition (27) 
Migraine without Aura  
A. Five attacks of headache fulfilling criteria B–D  
B. Headache  lasting 4–72 hours which were untreated or unsuccessfully treated. 
C. Headache has two of the following characteristics: located unilaterally, of pulsating  
quality , intensity of pain which is moderate or severe, aggravation by or causing avoidance 
of routine physical activity. 
D. Headache having one of the following: nausea and/or vomiting, photophobia, and 
phonophobia 
E. Cannot be related   to another disorder  
Typical Aura with Migraine Headache 
A. Two attacks of headache fulfilling criteria B–D 
 B. Aura consisting of at least one of the following, but no motor weakness: 
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  fully reversible visual symptoms including positive and/or negative features, fully reversible 
sensory symptoms including positive and/or negative features, fully reversible dysphasic 
speech disturbance. 
C. At least two of the following: homonymous visual symptoms and/or unilateral sensory 
symptoms, at least one aura symptom develops gradually over 5 minutes and/or different aura 
symptoms occur in succession over 5 minutes, each symptom lasts 5 and 60 minutes. 
D. Headache fulfilling criteria for migraine without aura begins during the aura or follows 
aura within 60 minutes. 
E. Cannot be related to another disorder. 
PATHOPHYSIOLOGY 
The pathophysiology of Migrainous vertigo despite intense study is still poorly understood. 
Migraine sufferers are more sensitive to numerous unpleasant sensory inputs and these inputs 
trigger a threshold which causes a cortical event followed by a brainstem event causing more 
input to be perceived as noxious resulting in headache. Sensory inputs that are not disturbing 
to non migraineurs like bright light, loud sound, motion and smell can be to people suffering 
from migraine. Thus the brain of migraine suffers are hyperexitable. Thickening of sensory 
cortex in migraine sufferers is reported in certain studies. Migraine sufferers are sensitive to 
sensory inputs even outside the period of headache. According to studies 45 % of children 
and 50% of adults gave a positive history of motion sickness (18, 28). 
Vascular dysregulation is also considered a part of the pathophysiology. Migraine aura may 
represent vasoconstriction and cortical hypoxia. It is also regarded as a cortical neuronal 
process (29). Both vascular dysregulation and abnormal electrical activity such as cortical 
spreading depression of Leao (29) and changes in occipital area seen in visual auras are 
implicated in aura of migraine (29). The trigeminal brainstem circuit dysfunction is also 
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implicated as a pathophysiology for Migrainous headache (29). This can be explained by the 
response to serotonin agonists given during the episode of migraine. 
Trigeminal neuron cell bodies contain a vasodilator peptide called calcitonin gene related 
peptide which is released during a sensory input overload triggered cortical circuitry which in 
turn increases painful input (29). Triptans block these receptors. Similar mechanisms are 
proposed for Migrainous vertigo. The cortical spreading depression may play a role in 
patients who are having short attacks (30). The cortical spreading depression can produce 
vestibular symptoms when the sensory cortical areas at the posterior insula and 
temporoparietal junction are involved (7). Canal paresis and complex positional nystagmus 
however cannot be explained by this phenomenon (31). Calcitonin gene related peptide, 
serotonin, adrenaline and dopamine involved in the pathogenesis of migraine also modulate 
the activity of a number of central and peripheral vestibular neurons thus contributing to the 
pathogenesis of vestibular migraine (7,32 ,33,34). The unilateral release of these substances 
causes one sided headache and a static vestibular imbalance resulting in rotatory vertigo. 
Bilateral release of these substances could result in motion sickness type of dizziness. 
Migraine and vertigo are prominent symptoms in familial hemiplegic migraine and episodic 
ataxia type 2 and an abnormal voltage gated calcium channel gene were found in them (35). 
This prompted the search for a susceptibility gene for Migrainous vertigo which so far has 
not been identified (36, 37). 
GENETICS 
Episodic vertigo has been associated with certain genetic syndromes, few of them having 
known genes. Episodic vertigo has been reported in episodic ataxia type 2 and is strongly 
associated with it. It has also been reported in episodic ataxia TYPES 134 (35,38,39 ,40). EA 
type 2 is allelic with familial hemiplegic migraine and about 50% of cases report migrainous 
headaches (35). In his study of 24 probands, Oh found 40% incidence of benign recurrent 
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vertigo in relatives as compared to only 2% in unrelated spouses and this was correlated with 
a high incidence (46%) of migraine in them. In 22 of the cases where more than one 
generation was affected, an autosomal dominant inheritance pattern was found the most 
likely (7). This study found an association with 22q12. A majority of these cases also had 
Migrainous headache.  
 
CLINICAL FEATURES 
Migrainous vertigo can occur at any age and has a female preponderance; the ratio being 1.5 
and 5 to 1 (6,7,19,32,33). It shows an autosomal dominant pattern of inheritance with 
decreased penetrance in men. Migrainous headache begins earlier than vestibular migraine in 
most patients (6, 19). Some of them may be free from migraine for a few years and may 
manifest vestibular migraine later, like women may develop vestibular migraine after 
menopause that may have had Migrainous headache earlier in their life. Vestibular migraine 
is common in migraine without aura than in migraine with aura (18). 
Vestibular Migraine in Children 
One of the early manifestations of vestibular migraine in children is benign recurrent 
paroxysmal vertigo. This can be characterised by short attacks of vertigo or unsteadiness, and 
often nystagmus, nausea or vomiting recurring for months or years (41). These children may 
develop Migrainous headache later in life (42). There is a two fold increase in first degree 
relatives according to certain studies (42). In a population-based study, the prevalence of 
recurrent vertigo probably related to migraine was estimated at 2.8% in children between the 
ages of 6 and 12 years (43). 
VESTIBULAR MIGRAINE IN ADULTS 
In a recent study of migraine associated vertigo, it was found out that the most common 
vestibular symptom is rotational vertigo (70%), intolerance to motion (48%) and positional 
 16 
vertigo (22%) (19). The onset of the disease can be gradual to abrupt. The duration of the 
disease was also found to be variable. The most common duration according to Neuhauser 
and his colleagues was 5- 60 minutes (33%), followed by 1-24 hours (21%), few seconds to 
minutes (18%) and more than 24 hours (2%)(19). It may take several days to weeks for the 
attack to subside and the attacks can be weeks to months to years apart. The spontaneous 
vertigo can transform to positional vertigo after several days to weeks (44). Positional vertigo 
is different from benign paroxysmal positional vertigo in duration of single attack, total 
duration of symptomatic episodes and the type of nystagmus. The patients need not 
experience positional vertigo with each attack although 40-70% of patients experience it (18). 
Head motion intolerance which is similar to motion sickness which is imbalance and nausea 
or vomiting provoked by head movement is experienced by a certain number of patients (32). 
Visual vertigo which is dizziness stimulated by a moving object is also a common feature 
(32,45). Nausea and unsteadiness are also common but are not specific for Migrainous 
vertigo. The vertiginous attacks may precede the headache, occur along with it or can occur 
after the episode of headache. Thus some patients experience vertigo with headache 
constantly (45%) or without headache sometimes (48%) and some never experience headache 
and vertigo together (6%). A good number of patients have photophobia (70%), phonophobia 
(64%), osmophobia, visual auras during an attack and auras other than vertigo (36%) (19).  
Some patients may present with aural complaints like hearing loss (32%) and tinnitus (32%) 
and some may have fluctuating hearing loss and aural fullness (11%) (8).The hearing loss 
may be mild and transient which usually is non progressive. Less common symptoms include 
a sensation of rocking, tilting, and walking on an uneven surface and unsteadiness. Similar to 
triggers for migraine, numerous triggers for migraine associated vertigo is also identified in a 
minority of patients. The triggers are numerous but a few seem to occur more frequently than 
others. The weather related triggers include changes in barometric pressure, and change in 
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seasons. The sensory stimuli triggers include bright or scintillating lights, intense smells, and 
noise. Other triggers could include physical exertion, decreased sleep, menses and 
dehydration while the common dietary triggers include matured cheese, red wine, glutamate, 
and change in pattern of caffeine intake, alcohol, chocolate and nitrites. Even when the 
triggers and manifestations are absent a diagnosis of MV can be made after excluding other 
causes of vertigo. The favourable response to anti migrainous drugs also supports the 
suspicion of a migraine mechanism. In summary the manifestations of MV is variable and the 
diagnosis is usually made on clinical suspicion, exclusion of other causes of vertigo, 
occurrence of migraine triggers and probably response to anti migraine drugs. The various 
manifestations of vestibular migraine in a study of 33 patients by Neuhauser are given below 
 
Clinical features of definite vestibular migraine in 33 patients(19) 
Clinical Features % 
Vestibular symptoms 
Positional vertigo         42% 
Head motion intolerance     48% 
Rotational vertigo                                           70% 
Other illusory self- or object motion            18% 
 
Duration of vestibular symptoms 
Seconds to 5 minutes                                      18% 
5 to 60 minutes                                                 33% 
1 hour to 1 day                                                  21% 
>1 day                                                                   2% 
Migrainous symptoms during vertigo 
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Migrainous headache                                      94% 
Always                                                                47% 
Sometimes                                                        48% 
No headache                                                      6% 
Photophobia                                                     70% 
Phonophobia                                                    64% 
Visual or other auras                                       36% 
PHYSICAL EXAMINATION IN MIGRAINOUS VERTIGO 
The clinical examination in these patients, both neurological and otological especially in the 
symptom free period will be normal (7). At times they can have nystagmus (18, 31) which 
can be made out by Frenzel goggle examination (46). About 20% of vestibular migraine 
patients will have a one sided decreased response on caloric testing and 10 % will have 
directional preponderance of nystagmus responses (6, 7). 
These findings are not specific for the disease and can be seen in other vestibular syndromes 
as well. There are studies which show mild occulomotor deficits in absence of other brain 
stem or cerebellar signs (6), vestibular migraine patients are four times more nauseous than 
migraine with other vestibular syndromes during caloric testing (47). In a study of 20 patients 
of vestibular migraine during their acute phase, all but one had imbalance and swaying during 
Romberg’s and tandem walking. Pathological nystagmus was observed in 14 patients. Unlike 
benign paroxysmal positional vertigo, the nystagmus is maintained until the position is 
maintained and it is not in the plane of positioning. Some of the patients had a unilateral 
deficit of vestibulo-ocular reflex, central vestibular dysfunction and peripheral vestibular 
dysfunction (31). 
In clinical practice as there are no symptoms specific for vestibular migraine, the history will 
usually provide the clue to diagnosis than vestibular testing. If the history is clear cut, then 
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the vestibular tests are not necessary. Testing during the period of attack, will reveal certain 
abnormalities which usually disappear after a few days to weeks and testing when the patients 
are asymptomatic will show no abnormalities. 
TESTING FOR MIGRAINE RELATED VERTIGO 
Migrainous vertigo is a diagnosis of exclusion. The most crucial overlap is with other 
otological diseases and for this reason, an otological and vestibular screening is advisable. 
The most useful tests include audiometry (to rule out Meniere’s disease and labyrinthitis) and 
vestibular evoked myogenic potential or video nystagmography, to rule out vestibular 
disorders. Various other tests done in migraine associated vertigo include otoacoustic 
emissions (48), brainstem evoked response audiometry (8, 49), posturography (51, 52) 
vestibular evoked myogenic potential (50), rotatory chair testing (32, 51), and caloric  testing 
(52). 
All these are done primarily to exclude other disorders as there is no specific diagnostic test 
for the disease. Oculomotor testing is also done to exclude other conditions and also 
according to Von Brevern and colleagues (31), there are minor oculomotor abnormalities in 
70% of patients with vestibular migraine. Brain imaging also done to exclude other disorders 
is normal all patients. However a recent meta–analysis showed that there are white matter 
abnormalities in 23% of migraine patients and they are at four fold risk of developing white 
matter abnormalities than people without migraine (53). 
The imaging findings are scattered punctate foci of T2 and fluid-attenuated inversion 
recovery signal hyper intensity in the deep cerebral white matter. There are rare cases of 
hearing loss in Migrainous vertigo (54, 55) which is usually transient and episodic (56). 
Cases of permanent hearing loss can be due to Migrainous infarction .However currently 
there is only limited data to suggest hearing loss in migraine associated vertigo. The present 
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clinical experiences suggest almost all patients with migraine associated vertigo have normal 
hearing, except when combined with Meniere’s disease. 
Pure tone Audiometry (57) 
Pure tone audiometry is a behavioural test used to measure the hearing sensitivity and it 
measures both central and peripheral auditory systems. The tests done are plotted on a graph 
called audiogram which displays the intensity of sound as a function of frequency. The 
various degrees of hearing loss are; 
Normal hearing loss-0 to 25 d B 
Mild hearing loss- 26 to 40 d B 
Moderate hearing loss-41 to 55 d B 
Moderately severe hearing loss-56 to 70 d B 
Severe hearing loss-71 to 90 d B 
Profound hearing loss- >90 d B 
Types of hearing loss 
1. Conductive hearing loss-here the bone conduction thresholds will be normal and but 
the air conduction thresholds are higher by at least 10 decibels when compared to 
normal. E g-chronic otitis media. 
2. Sensorineural hearing loss-Here the bone and air conduction thresholds are within 10 
decibels of each other, but the bone conduction thresholds are higher than 25 decibels. 
E g- presbyacusis 
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3. Mixed hearing loss-here there is involvement of both the conductive as well as 
sensorineural components where the air and bone conduction thresholds are more than 
10 decibels apart and the bone conduction thresholds are more than 25 decibels. 
Pure tone average is the average of the hearing sensitivity at 500 Hz, 1000 Hz and 2000Hz. 
The primary purpose of doing an audiogram is to determine the type, degree and 
configuration of hearing loss. It can not be done in young and unco operative individuals and 
patient suffering from other medical conditions. No anaesthesia is required for the procedure.  
Pure tone audiometry is routinely done in all cases of migrainous vertigo. There are only 
limited studies which shows migrainous vertigo patients having hearing loss (8). In Dash et 
al’s study 7 out of 38 patients of migrainous vertigo had mild sensorineural hearing loss 
documented. 
Impedance  Audiometry.(57) 
Tympanometry and acoustic reflexes are routinely done in all cases of migrainous vertigo. A 
normal (type A) tympanometry confirms a normal middle ear function which is essential for 
testing for otoacoustic emissions and auditory brain stem potentials. 
The acoustic reflex tests the integrity of the acoustic reflex pathway. The reflex pathway 
consists of an afferent (cochlea and auditory nerve) and efferent pathway (fibres from 
brainstem to the facial nerve and stapedius muscle 
Brain stem evoked response audiometry (BERA). 
Auditory brainstem response audiometry testing is an objective test which assesses the 
auditory pathway from the auditory nerve to the brainstem, electro physiologically. After a 
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sound stimulus is presented, it occurs in the first 10 milliseconds, hence is considered a short 
latency potential. 
The BERA consists of seven waves and of these waves 1, wave III and wave V are the most 
seen and robust and are of more clinical significance. The different sites at which these waves 
are generated are – 
Wave 1- most distal portion of the auditory nerve in relation to the brainstem. 
Wave II- proximal portion of auditory nerve in relation to the brainstem. 
Wave III-cochlear nucleus 
Wave IV –superior olivary complex 
Wave V-lateral leminiscus 
Wave VI-inferior colliculus 
Wave VII-medial geniculate body (58,59) 
Recordings of this potential may be analysed clinically using various parameters, 
1. Morphology of the waves 
2. Absolute latency and amplitude of wave I,III and V 
3. Interpeak latencies-wave1-III,wave III-V and wave 1-V 
4. Wave 1 -V latency and amplitude relation 
5. Wave 1 -V latency inter aural difference or wave 5 absolute latency differences. 
Of these parameters, the most widely used clinically are the interpeak and absolute 
latency interval measurements (59). 
According to studies, the main clinical aims and uses of BERA are, 
1. To establish a minimal auditory response level 
2. To delineate the type of hearing loss 
3. To assess the maturity of the central nervous system in neonates. 
4. To investigate the site of auditory nerve or brain stem injury 
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5. To monitor surgery of posterior fossa 
6. To monitor patients in intensive care units (60) 
There are certain factors which can influence the interpeak and absolute latencies of the test. 
The physiological factors which influence the values according certain studies are subject 
related features such as age, sex and hormonal status. Certain studies revealed increased wave 
latencies in BERA testing in subjects aged over 60 years while in some studies there was no 
statistically significant variation with age (61). Other studies have shown that latency 
measures (especially wave V) and interpeak intervals (especially in the I-V interval) are 
higher in male subjects compared with female subjects (62). 
Thus, both age and sex are mentioned as variables that may alter BAEP recordings; their true 
influence, however, remains controversial, requiring additional studies of these issues. 
BERA potentials are recorded from the scalp by disc or cup electrodes which are the 
responses to high intensity clicks which are given at a rate of approximately 10 per second. 
These potentials are typically present in persons with normal hearing and those with 
sensorineural hearing loss. There are only few studies on the BERA abnormalities in patients 
with migrainous vertigo (8).   As the degree of sensorineural hearing loss increases, the 
morphology of the potentials also will also change to the extent that it can be absent in 
profound sensorineural hearing loss (63). 
Otoacoustic emissions 
Otoacoustic emissions were first described by Kemp in 1978 as low intensity sounds 
generated by the outer hair cells of cochlea by their active movements (64,65). 
In general, spontaneous OAEs occur in only 40-50% of individuals who have normal hearing. 
For these adults, the range is about 30-60%; in neonates with normal hearing, the range is 
approximately 25-80%. These are a marker of cochlear function and the emissions are left 
intact even after the sectioning of auditory nerve. Transient clicks at 80- 86 db sound pressure 
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evoke the acoustic echoes and typically responses to 260 stimuli are captured over a time 
frame of first 20 milliseconds after application of the stimulus. 
There are 2 types of emissions; a transient evoked and a distortion product oto acoustic 
emission. The transient evoked emissions are present if the response amplitude after 
reduction of background noise is 4 decibels or more and the wave form is reproducible in at 
least 3 octave bands. 
More frequency specific information can be obtained from distortion product emissions than 
from transient evoked emissions as it allows specific testing of a restricted region of outer 
hair cells. In distortion product emissions 2 continuous tones of 2 different frequencies (f1 
and f2) are given and the emissions are largest at the 2f1-f2 frequency. Otoacoustic emissions 
represent the acoustic equivalent of electric cochlear microphonics. Both these provide 
improved tuning of the inner ear and enhance threshold activity. 
Though OAES provide valuable information regarding outer hair cell function, there is no 
accurate way to measure inner hair cell function. 
Prerequisites for obtaining otoacoustic emissions 
Prerequisites include the following: 
 An ear canal which does not have any obstruction. 
 The probe should seal the ear canal. 
 Correct situation of the probe 
 Normal middle ear function: Pressure equalization (PE) tubes alone probably will not 
interfere with results. However, if emissions are absent, results should be interpreted 
with caution.  
 Normal functioning outer hair cells. 
 A quiet patient: Excessive movement or vocalization can give a wrong interpretation. 
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 A quiet recording environment:  a noisy environment may preclude accurate 
recording. 
Non pathologic problems that can cause absence of OAEs 
 Poor placement of probe tip or not obtaining proper seal 
 Standing waves, however most equipment alerts the person doing the test about these. 
 Wax blocking the canal or  probe port 
 Debris and foreign bodies in the external auditory canal 
 Vernix caseosa in neonates: This is common immediately after birth. 
 Uncooperative patient 
Pathologic problems that can cause absence of OAEs 
Outer ear 
 Otitis externa 
 Stenosis of external auditory canal 
 Any lesions in the external canal like a cyst 
 Variations in the middle ear pressure 
 Perforations of tympanic membrane 
Middle ear 
 Ossicular discontinuity 
 otospongiosis 
 chronic otitis media, squamous or mucosal 
 Cyst 
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Inner ear (Cochlea) 
 Exposure to ototoxic medication  
  noise exposure . 
 Any other cochlear pathology 
Conditions that do not affect OAEs 
 Auditory nerve pathology: If auditory nerve  pathology also affects the cochlea, OAEs 
are affected.  
 Central auditory disorder 
Conditions that elicit abnormal OAEs and normal behavioural thresholds 
 Tinnitus: OAEs may be abnormal in the frequency region of the tinnitus. 
 Excessive noise exposure  
 Any intake of ototoxic drugs 
 Any Vestibular pathology 
Conditions that elicit normal OAEs and abnormal behavioural thresholds 
 Functional hearing loss 
 Attention deficits 
 Autism 
 Possibly, inner hair cell damage but normal outer hair cells (reported for animals but 
no human reports yet) 
 Auditory neuropathy: This includes central auditory nervous system dysfunction and 
CN VIII auditory dysfunction. 
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Uses of Otoacoustic emissions 
 Simple, non invasive hearing tests for neonates as well as those not co operating 
for conventional hearing tests. 
 Assists in the differential diagnosis of various cochlear and central auditory 
pathologies. 
 Biometric identification 
 As it is an objective test, it is useful in investigating inorganic hearing loss and 
demonstrating normal cochlear function to the patient. Literature has been silent 
regarding the abnormalities of OAEs in Migrainous vertigo. 
DIFFERENTIAL DIAGNOSIS OF MIGRAINOUS VERTIGO 
When headache and dizziness coincide, the most likely diagnosis is vestibular migraine. The 
difficulty in diagnosis is when these two does not coincide or when there is no headache at 
all. According to recent studies, migraine may be triggered by dizziness itself the various 
other disorders we can think of are as follows (66)., 
1) Benign paroxysmal positional vertigo(BPPV)-Here the vertigo lasts for seconds to 1 
minute and is provoked by changes in head position and there is a positive positional test 
result with typical geotropic torsional nystagmus. 
2) Meniere’s Disease- The Vertigo lasts for 20 minutes to 3 hours with Features of 
fluctuating hearing loss, tinnitus, and aural fullness and progressive hearing loss over years 
(67). 
3) Central positional vertigo-here the features are similar to BPPV but the direction of 
positional nystagmus, duration and latency are not similar to that of BPPV; as the vertigo is 
central, neurologic or neurotologic features will also be present. 
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4) Vertebrobasilar transient ischemic attack-the vertigo lasts for a few minutes, with brain 
stem symptoms, ataxia, dysarthria, double vision or visual field defects. Elderly patients with 
vascular risk factors like hypertension, diabetes mellitus and dyslipidemia are prone to have 
such symptoms. 
5) Vascular compression of the eighth nerve presents with short  attacks of vertigo lasting a 
few seconds for several times in a day with or without auditory symptoms and such patients 
often responds to carbamazepine. 
6) Perilymph fistula –the Vertigo occurs after a history of head trauma, barotrauma, or 
stapedectomy or violent coughing, sneezing, straining, or loud sounds. 
7) Autoimmune inner ear disease-there will be attacks of vertigo of variable duration; with 
rapidly progressing hearing loss and insufficient compensation of unilateral vestibular loss, 
but bilateral loss is also common. There will be brief and mild spells of vertigo during rapid 
head movements, oscillopsia when head turns to affected ear and a positive result of head 
thrust test to the affected side. 
8) Schwannoma of the eighth nerve-in this condition, the patients rarely presents with vertigo 
as a complaint. They can have mild  attacks of vertigo, the most common symptoms are a 
slowly progressive unilateral hearing loss and tinnitus and  abnormal Brain stem evoked 
response audiometry with poor wave form morphology. 
MIGRAINE ASSOCIATED VERTIGO SYNDROMES 
Migraine and Meniere’s disease 
There is an increased prevalence of migraine (22-76%) in patients with Meniere’s disease, 
though the pathophysiologic association is not well understood(68). The prevalence of 
migraine in Meniere’s (American Academy of Otolaryngology 69) is twice as seen in age and 
sex matched controls. Patient having migraine has an increased susceptibility of developing 
earlier manifestations of Meniere’s disease than without migraine. Vestibular testing also 
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provide little information to differentiate between the two (70). In vestibular migraine the 
hearing loss will be mild, transient, and non progressive whereas in Meniere’s disease the 
hearing loss is severe and progressive (33). However migraine can mimic Meniere’s disease 
and can even lead to inner ear damage and delayed endolymphatic hydrops (54). At times it is 
difficult to differentiate between the two disorders clinically (68). Both these conditions may 
be different manifestations of the same susceptibility and may have a genetic basis also (70). 
There are familial forms of Meniere’s disease in which there will be increased prevalence of 
migraine, no hearing loss and episodic vertigo making the migraine-Meniere’s syndrome 
genetically distinct from Meniere’s disease alone (71). 
 
Association of migrainous vertigo with Meneire’s disease and hearing loss 
Migraine and Benign paroxysmal positional vertigo 
 
Although clinically separate entities, certain studies found a link between the two. Migraine 
was three times more common in those with idiopathic BPPV than with BPPV secondary to 
Hearing 
loss 
Meniere’s 
disease 
Migrainous 
vertigo 
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surgery or trauma and two times more common in idiopathic BPPV than in age and sex 
matched controls (72). A retrospective study by Uneri of 476 patients of BPPV found 54.8% 
of them having migraine (73). In BPPV, the degenerating otoconia movement produces 
movement of endolymphatic fluid in the labyrinth resulting in a short spell of dizziness which 
has a true rotatory vertigo, nausea and imbalance. On positional testing there will be a brief 
torsional geotropic nystagmus, which is successfully treated by the particle repositioning 
manoeuvre (74). This has to be distinguished from the positional vertigo in vestibular 
migraine (75). Thus migraine can be considered as a risk factor for developing BPPV. This 
association may due to the ischemic changes due to vasospasm to the otoliths (54, 55). 
Migraine and motion sickness 
Various studies have shown that Motion sickness occurs more frequently in patients who 
have migraine (30%–70%) than in controls who have tension headache or in headache-free 
controls (20%–40%) (18,45). The prevalence is increased in children and migraine with aura 
(76). Optokinetic stimuli induced visual vertigo is also common in migraine (45). Apart from 
that, photophobia, headache and scalp tenderness can be easily caused by optokinetic 
stimulation in patients who have migraine than in controls. It may be difficult to differentiate 
between episodic motion sickness and attacks of VM induced by motion stimuli. The only 
differentiating points could be the duration and type of symptoms. In vestibular migraine the 
rotational or positional vertigo will usually persist even after the motion stimuli while the 
dizziness due to motion sickness will improve after the motion stimuli is removed. Chronic 
VM may be explained by a constantly lowered threshold to motion stimuli. Interestingly, 
motion sickness could be prevented using rizatriptan in migraineurs who had VM but not in 
patients who had migraine alone (77,78). 
Benign recurrent vertigo of childhood 
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Basser in his studies described a recurrent paroxysmal vertigo occurring in children 
particularly below 8 years which was of very short duration lasting for seconds to minutes 
and had a benign prognosis (41). Fenichel later in studies described the association of 
migrainous headaches and benign recurrent vertigo (79). Long term follow up studies 
suggested that there is a strong association of (both family history and personal history) 
migraine headaches and benign vertigo in childhood. These children also had a high 
prevalence of motion sickness (80). 
Basilar Migraine 
In basilar migraine, vertigo is one of the most common symptoms (2).which has been 
included in the current international headache society classification of headaches. For a 
diagnosis of basilar migraine there should be an aura of bilateral visual field abnormalities 
and at least two symptoms suggestive of brainstem involvement along with migrainous 
headache (2).  The majority of patients with migraine and vertigo do not qualify for a 
diagnosis of basilar migraine as the vertigo attacks are often separate from the headaches and 
the duration of the vertigo often does not fall within the restrictions for aura (5-60 min) 
(1,6,19,24). 
Migraine and cerebellar dysfunction 
Dizziness can be as a result of Cerebellar dysfunction which causes imbalance. A rare 
subtype of migraine which is Familial hemiplegic migraine can develop cerebella ataxia 
which is progressive and can also have nystagmus. In FHM, episodic ataxia type 2 and 
spinocerebellar ataxia type 6,there are mutations identified in the CACNA1A gene which is 
coding for the a1A subunit of a neuronal Ca21 channel which is expressed in the cerebellum 
heavily. EA-2 is characterized by nystagmus which is interictal, cerebellar ataxia and vertigo. 
Half of the patients who have EA-2 have migrainous headache and FHM and EA-2 are 
associated with symptoms of basilar migraine. In more common types of migraine, Cerebellar 
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symptoms are not usually present in the more common type of migrainous headaches, but sub 
clinical hypermetria and other subtle sub clinical cerebellar signs in patients who have 
migraine with or without aura have been reported. The possible cause for this could be the 
gene mutation as mentioned above. This hypothesis relies on findings of involvement of the 
CACNA1A gene region in some families who have non hemiplegic migraine with and 
without aura. Another possible link between migrainous vertigo and cerebellar  dysfunction  
was as a result of the  mild occulomotor deficits of cerebellar origin observed in patients who 
have migrainous vertigo. (81,6). 
Migraine and non vestibular dizziness 
The prevalence of vertigo as well as dizzy spells in migraine patients is more compared to 
controls. The dizzy spells can be attributed to non vestibular causes. However mild vestibular 
dysfunction can also present as dizzy spells. 
Migraine, orthostatic hypotension and syncope 
It has been seen in studies that 5% of 500 migraine patients develop syncope during migraine 
attacks. In a large based population survey, the prevalence of syncope and orthostatic 
hypotension was found to be higher in migraine patients than in controls. However orthostatic 
hypotension can be caused dopamine agonists and can be counteracted by antagonists in 
migraine patients but not in controls. This suggests dopaminergic hypersensitivity as the 
underlying cause (83). 
Migraine, dizziness and psychiatric disorders 
Studies have shown that migraine, dizziness and certain psychiatric disorders are interrelated. 
It has been shown that migraine is a risk factor for major depression and panic attacks and 
vice versa and the association of migraine with these disorders have also been documented. 
Dizziness is the second most common symptom of panic attacks after palpitation as well as 
depression. Studies have shown there are vestibular tests abnormalities in patients with panic 
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and anxiety disorders suggesting that those with vestibular abnormalities have an increased 
risk of developing an anxiety disorder. As compared to other vertigo syndromes vestibular 
migraine patients show increased rates of concurrent anxiety and panic disorders. Because of 
this association, a new syndrome, migraine anxiety related dizziness has been proposed (84, 
85). 
Dizziness and anti migraine drugs 
Dizziness is a side effect of many drugs used in the treatment of various conditions as well as 
for migraine. Thus a detailed drugs history should be asked for during history taking. Beta 
blockers can cause orthostatic hypotension initially and tricyclic antidepressants used in 
prophylaxis of migraine can cause orthostatic hypotension, light headedness and blurred 
vision. 
 
 
 
 
 
 
 
 
 
 
 
   
 
MATERIALS AND METHODS 
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This study was carried out in the ENT Department’s out-patient and in the Audio vestibular 
Clinic (AVC) of the Christian Medical College, Vellore, a tertiary health care facility. 
 
SELECTION OF CASES 
The first part of the study was to review the charts of the patients visiting Audio vestibular 
clinic in CMC for a period of six months, retrospectively. It is routine practice in the clinic 
that a preformatted questionnaire is used to record the history of vertigo patients and 
complete filling up of the questionnaire is strictly implemented. The details required to make 
a diagnosis of migraine has already been included in this questionnaire.  In those records 
where a diagnosis of Migrainous vertigo had been made, demographic details were collected 
as well as information of the audiometric tests (pure tone audiometry and impedance 
audiometry).  
 The age and sex distribution of Migrainous vertigo was calculated from the data and the type 
of hearing loss in the patients was also calculated. The average hearing loss in the frequencies 
500Hz, 1Hz, 2Hz at different age groups were calculated along with the frequency of 
Migrainous vertigo. 
The second part of the study included thirty patients in whom a diagnosis of Migrainous 
vertigo was made using the same questionnaire. The inclusion and exclusion criteria for the 
subjects were as follows: 
Inclusion Criteria 
a. Age between 18 to 60yrs 
b. All patients with Migrainous Vertigo 
Exclusion Criteria 
Any patients with typical history of BPPV (and a positive Hall pikes test) 
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Any patients with typical Meniere’s disease (AAOC criteria 1995) 
Any patient with past history of chronic discharging ears/history of surgery to ear/ history of 
permanent hearing  loss. 
Other neurological disorders such as stroke and intracranial tumours, anyone with prolonged 
noise exposure, history of ototoxic  medications, otosclerosis or with  a history of head or ear 
trauma,  diabetes mellitus, hypertension or ischemic heart disease. 
Relevant blood tests were done to do exclude patients with dyslipidemia, diabetes mellitus 
and hypothyroidism and anaemia. All those selected for the study patients underwent 
otoneurological investigations consisting of pure tone audiometry (PTA), impedance 
audiometry (IA), auditory brainstem response audiometry (BERA) and distortion product 
otoacoustic emissions(DPOAE).   Thirty age matched normal controls were also selected and 
the additional tests were also done on them to compare the inter-peak and absolute latencies 
and presence or absence of otoacoustic emissions with that of the subjects. 
PROCEDURE 
PTA was done using a GSI-Grason Stadler diagnostic audiometer. Hearing thresholds of 15-
25 dB across the frequencies 250 Hz -8000 Hz were considered normal. The Glason Stadler 
GSI Tympstar impedance audiometer was used to obtain immittance measurements. The test 
was performed using a probe with tone frequency of 226 Hz. An ipsilateral stapedial reflex at 
1000 Hz was elicited. The ipsilateral acoustic reflex threshold was taken as normal if the 
level at which it was elicited fell between 70 dB and 100 dB. 
                                       DPOAE were tested using the INTELLIGENT HEARING 
SYSTEMS. It was recorded using a test protocol where preliminaries were fixed at L1 
equalling 65 dB SPL, L2 equalling 55 dB SPL with an f2/f1 ratio of 1.22. The f2 frequencies 
were carefully selected to correspond closely to audiometric test frequencies of 1000 Hz, 
2000 Hz and 4000 Hz. The testing was done at 1000 Hz, 2000 Hz, 3000 Hz, 4000 Hz and 
 36 
6000 Hz. A response is considered to be present if the SNR is more than 6.13 dB. The 
DPOAE was recorded with amplitude in dB SPL as a function of stimulus frequency. This is 
commonly called as a DPOAE gram. The f2 frequencies are presented on the horizontal axis 
and amplitude of the DPOAE for the different frequencies is plotted on the vertical axis. 
                                    Brain stem evoked response audiometry (BERA) was done using 
INTELLIGENT HEARING SYSTEM launch pad version 2.32 X. Smart EP software under 
Microsoft windows version XP 2002 and is primarily controlled by the mouse with push 
buttons and menus. 
CASE DEFINITIONS 
1. Normal hearing: pure tone average 500 Hz, 1000 Hz and 2000 Hz with bone 
conduction threshold less than 25 dB and air conduction thresholds at 20 dB. 
2. Mild sensory neural  hearing loss:  pure tone average 500 Hz,1000 Hz and 2000 Hz 
with bone conduction between 26-40 dB 
3. Moderate sensory  neural hearing loss:  pure tone average 500 Hz,1000 Hz and 2000 
Hz with bone conduction between 41-55 dB 
4. Moderately severe sensory neural hearing loss:  pure tone average 500 Hz,1000 Hz 
and 2000 Hz with bone conduction between 56-70 dB 
5. Severe sensory neural hearing loss: pure tone average 500 Hz,1000 Hz and 2000 Hz 
with bone conduction between 71-90 dB 
6. Profound sensory neural hearing loss:  pure tone average 500 Hz,1000 Hz and 2000 
Hz with bone conduction more than 90 dB 
7. Conductive hearing loss-when air bone gap is more than 25 dB 
8. Poor wave form morphology on auditory brainstem response testing: waveforms 
showing prolongation of inter peak latencies i. e wave I to V delay more than 3.84 
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milliseconds with standard deviation of 0.16 or abnormal amplitude ratios. The 
normal wave latencies are shown below. 
       
90  DB nHL Mean (milliseconds) Standard  deviation 
Absolute latency Wave 1 1.54 0.09 
Absolute latency Wave 
III 
3.6 0.12 
Absolute latency Wave 
V 
5.43 0.14 
Interpeak latency wave1-
III 
2.06 0.14 
Interpeak latency wave 
III-V 
1.82 0.14 
Interpeak latency of 
wave I -V 
3.85 0.16 
(n –reference to the normative group threshold click stimulus) 
9. The presence of oto acoustic emissions present was taken as the presence of true 
validated DPOAE and it means that normal cochlear function is present at the frequency 
of stimulus 
10. DPOAE absent was taken as absence of otoacoustic emissions over a more restricted 
frequency range, at least third of an octave indicating abnormal outer hair cell function 
(86). 
11. Impedance audiometry consisting of two components Tympanometry and acoustic 
reflex- A type curve indicates a normal tympanometric graph and indicates normal middle 
ear function. 
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Statistical methods:  
The retrospective part of the study was descriptive and provided statistics on what had been 
observed in the patients who were tested in the clinic. 
The prospective part of the study involved analysis of the absolute and inter-peak latencies of 
patients with migraine related vertigo compared to the standard normal. 
Sample size: About 400 patients are seen every year with Migrainous Vertigo in  the Audio 
Vestibular Clinic.  
Other studies indicate that abnormalities of the auditory pathway may be found from 36 to 
56% among patients with Migrainous Vertigo (2,55).  
Taking a conservative estimate that 20% of patients in the Audio vestibular clinic with 
Migrainous Vertigo would have abnormalities of the auditory pathway, a sample size of 88 
was taken with 44 patients with Migrainous vertigo and 44 age matched controls   to   provide 
an estimate that could range from 15% to 25% with a 95% confidence. 
 
 
 
 
 
 
RESULTS AND ANALYSIS 
 
There were two parts to this study. 
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The first part(retrospective chart review) 
 The first was a chart review of 400 patients’ charts who had visited the audio vestibular unit 
over a period of 6 months.  
Of the 400 charts reviewed, 363 patients (90.8%) presented with chief complaints of  
vertigo and 37 (9.3%)   presented with complaints other than vertigo. 
Among the 363 patients who presented with vertigo, 283 had complaints of  
vertigo other than migrainous vertigo, 80 (22%) (Table1). 
Table 1. Presentation of vertigo among the charts reviewed  
Presentation of vertigo Number of 
patients 
Percent 
Migrainous vertigo 80 22% 
Non-migrainous vertigo 283 78% 
Total 363 100% 
 
 
 
 
 
Fig 1.Percentage of  migrainous vertigo patients seen in clinic 
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Age breakdown showed that ninety percent were between the ages 31 and 50 (Table 2,fig 1). 
Most number of patients were found in age group 31-40(58%), followed by age group,41-
50(33%). 
 
 
 
 
 
 
 
Table 2-Age distribution of migrainous vertigo patients 
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Age groups (years)  Number (%) 
0-20 2 (3) 
21-30 4 (5) 
31-40 46 (58) 
41-50 26 (33) 
51-60 1 (1) 
Above 60 1 (1) 
Total 80 (100) 
 
 
 
Fig 2-Age distribution of Migrainous vertigo patients 
 
 
 
The sex distribution showed 44 (55%) were females and 36 (45%) were males. Most of  
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the patients with a  diagnosis of migrainous vertigo  had normal hearing (53 of 80); 26 of 80 
had bilateral mild sensorineural hearing loss (SNHL) and one patient had unilateral mild 
sensorineural hearing loss ( Table 3). 
Table  3. Type of hearing loss in migrainous vertigo 
Hearing loss Number (%) 
Normal hearing 53 (66) 
Unilateral mild SNHL 1 (1) 
Bilateral mild SNHL 26 (33) 
Total 80 (100) 
 
 
 
 
 
 
Fig 3.Type of hearing loss in Migrainous vertigo 
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66%-patients with normal hearing, 33%-patients with mild sensory neural hearing loss,1%-
patient with unilateral sensory neural hearing loss. 
Of the twenty seven patients who presented with mild sensorineural hearing loss 16 were in 
the age group of 31-40  years; 9 were in the 41-50 years age group and one each was in the 
21-30 and 51-60 years age groups.  
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Fig 4. Age categories and number of patients with hearing loss 
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 Second part of the study:(prospective case controlled) 
Table 4 shows the distribution of age of Migrainous patients and controls. Most of the patients 
and the controls were in the age groups 20 to 40 years(80% and 93% respectively) 
Table 4. Age distribution of cases 
and controls 
Age 
Years 
Cases 
No. (%) 
Controls 
No. (%) 
20-30 8 (27) 18 (60) 
31-40 16 (53) 10 (33) 
41-50 6 (20) 2 (7) 
Total 30 30 
 
There were 11 males and 19 females in the study group while there were 16 males and 14 
females in the control group. 
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The ENT and otoneurological examination in all patients and controls were normal. 
 
HEADACHE AND ITS DESCRIPTION AMONG THE CASES SELECTED: 
All the thirty patients had headache during their lifetime. For 27, the attacks were similar in 
nature each time (identical). Tables 5 shows the localisation of the headache. Since the 
choices are not mutually exclusive, each patient could have had more than one response and 
percentages will add up to more than 100. The most frequent site of headache was at the 
occipital region. 
Table  5. Headache and pain in the neck and its localisation 
 
Site of headache Number (%) 
Front of head 19(63.33%) 
Back of head 20(66.67%) 
Both sides of head 16(53.33%) 
Back of head and neck 11(36.67%) 
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Fig 5.Headache and its localisation 
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Twenty one patients had headache more than 11 years; and 9 had headache for 10 years or 
less. The duration of an average attack of headache lasted for an hour or less in 17 patients, 1 
to 2 hours in 12 and in one, for more than 2 hours (Table 6). A majority (83%) had two or 
more attacks of headache a month (Figure 4). 
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Table 6. Duration of an average attack of headache 
 
  
Hours Number (%) 
0-1 17 (57) 
1-2 12 (40) 
>2 1 (3) 
 
 
Fig 6.Duration of attacks 
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Fig 7-frequency of attacks 
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All 30 experienced a throb during attacks of migraine while 9 had dizzy spells when they did 
not have a headache. Nine had positional vertigo and 10 had motion sickness 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 8 .percentage of patients having positional vertigo 
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Fig 9.Percentage of patients having motion sickness 
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Headache in 25 patients was relieved by paracetamol, in 3 it settled on its own and in 2 by 
other measures.25 out of 30 patients had a positive family history of Migrainous headaches. 
 
Fig 10.Percentage of patients with positive family history 
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PATIENTS EXPERIENCING MIGRAINE WITH AURA 
Among the 30 patients, all experienced aura during the attack of headache or an hour before 
or after the attack of headache. At least one of the brain stem symptoms like  unsteadiness, , 
zigzag lights in vision, darkness in vision and double vision was experienced by all the 
patients tinnitus and hearing loss .  
Eighteen experienced zigzag spots in their field of vision, 25 experienced dark areas in the 
centre of field of vision, 5 experienced darkness in one half of field of vision.  
All patients experienced dizzy spells, unsteadiness was experienced by nine, five experienced 
double vision as aura during the attack of headache, 14 experienced noises in the ear as an 
aura, 4 experienced loss of hearing during the attack of migraine as an aura. None of the 
patients experienced episodes of loss of consciousness or black outs (Figure 5) 
. 
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Fig 11.Symptoms of aura present in patients with Migrainous vertigo 
 
 
 
 
ASSOCIATION OF HEADACHE WITH OTHER SYMPTOMS 
All patients experienced nausea with the attack of headache while 28 had both nausea and 
vomiting, two experienced only nausea.  Thirteen of the 30 experienced increased sensitivity 
to bright lights or photophobia and 13 had increased sensitivity to loud sounds (phonophobia). 
Five experienced disturbances in smell associated with headache. The dizzy spells of 16 out of 
30 patients of Migrainous vertigo were accompanied by auditory symptoms like tinnitus and 
decreased hearing  and phonophobia. Five out of the 30 patients with Migrainous vertigo had 
olfactory symptoms and 16 had auditory symptoms  with vertigo during headache free 
intervals. 
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Fig 12. percentage of patients experiencing photophobia 
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Fig 13.percentage of patients having phonophobia 
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Fig 14.percentage of patients experiencing auditory symptoms 
 
53%
47.00%
42%
44%
46%
48%
50%
52%
54%
percentage of 
patients
auditory symptoms no auditory symptoms
percentage of patients with auditory symptoms
 
Fig 15. Percentage of patients with olfactory symptoms 
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PHYSICAL EXAMINATION AND AUDIOLOGICAL INVESTIGATIONS 
The ENT and otoneurological examination in all 30 patients were normal.. All thirty patients 
underwent a pure tone audiometry (PTA), impedance audiometry(IA), distortion product 
otoacoustic emissions(DPOAE) and brainstem evoked response audiometry(BERA). 
 
Out of the 30 patients 10 had abnormal PTA and 20 had normal PTA 
All ten except one patient had bilateral mild sensorineural hearing loss; one patient had unilateral 
mild sensorineural hearing loss.  
Tympanometry  done to assess the middle ear function, showed normal A type curve in all 
patients. The stapedial reflux was present in all the 30 patients except one. 
 
The tables 7 to 9 show the test results in migrainous   patients with and without auditory symptoms   
There were no significant differences between the two groups for these tests. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7:  PTA results in migrainous patients with and without auditory symptoms 
 56 
 
Auditory symptoms (tinnitus, 
hearing loss and phonophobia) 
PTA abnormal 
(%) 
PTA normal 
(%) 
Present (n=16) 7 (44) 9 (56) 
Absent  (14) 3 (21) 11 (79) 
Total 30 10 20 
Chi.Sq=0.8203; df=1; p=0.3651 
 
 Table 8.  Auditory symptoms and BERA results 
Auditory symptoms (tinnitus, 
hearing loss and 
phonophobia) 
BERA abnormal (%) BERA  normal 
(%) 
Present (n=16) 14 (87.5) 2 (12.5) 
Absent  (14) 12 (86) 2 (14) 
Total 30 26 4 
Chi.Sq=0.1558; df=1; p=0.6930 
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Table 9.  Auditory symptoms and OAE results 
Auditory symptoms (tinnitus, 
hearing loss and phonophobia) 
BERA  abnormal BERA  normal 
Present (n=16) 6 (37.5) 10 (62.5) 
Absent  (14) 5 (35.7) 9 (64.2) 
Total 30 11 19 
Chi.Sq=0.0775; df=1; p=0.7807 
 
 
 
 
 
 
The tables 10 shows DPOAE results in migrainous patients with  normal and abnormal PTA.   
. There were no significant difference between the two groups for these tests 
 
 
 
Table 10  Status of OAE  in patients with normal and abnormal pure tone audiometry 
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Audiogram (PTA) DPOAE absent DPOAE present 
Normal (20) 7 (35) 13 (65) 
Abnormal (10) 4 (40) 6 (60) 
 Total (30) 11 19 
Chi.Sq=0.0179; df=1; p=0.8934 
The table 11 shows the  BERA test results in migrainous   patients with normal and abnormal PTA   
. There were no significant difference between the two groups for these tests 
Table 11.  Status of BERA in patients with normal and abnormal pure tone audiometry 
 
Audio ABR normal ABR abnormal 
Normal (20) 3 (15) 17 (85) 
Abnormal (10) 1 (10) 9 (90) 
Total (30) 4 26 
 
Chi.Sq=0.0361; df=1; p=0.8494 
 
All thirty patients underwent BERA and DPOAE testing. The values of these tests were compared 
with that of 30 normal controls. 
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Table 12 and 19 show the number of patients with normal and abnormal DPOAE   in the right 
ear and left ear respectively in patients and controls. This difference was statistically 
significant in both ears. 
 
 
Table 12. OAE Right ear Differences between cases and controls 
 
               OAE results Cases Controls Total 
 
Right ear 
Normal 
22 29 51 
  Abnormal 
8 1 9 
                        Total 
30 30 60 
 
Chi sq 6.4, P=0.011* 
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Table 13. OAE Left  ear Differences between cases and controls 
 
              OAE Results  Cases Controls Total 
 
Left ear 
Normal 
20 29 49 
  Abnormal 
10 1 11 
                     Total 
30 30 60 
 
Chi sq 9.01, P=0.003* 
 
 
Tables 14 to 18 show the number of patients with normal and abnormal BERA absolute 
latencies of waves I, III, and V   in the right ear and left ear  in patients and controls. The  
difference in absolute latency of wave V in the right ear was  statistically significant. 
Difference in all  other absolute latencies did not reach significance. 
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Table 14: Number of patients and controls with normal and abnormal absolute latency of 
wave I in the right ear and the test of significance  
 
Absolute 
latency of wave 
1,right ear 
Number of 
patients/controls Mean Std. Deviation Std. Error Mean 
Case 
30 1.5320 .09704 .01772 
Control 
30 1.5597 .16166 .02952 
 
t= -0.804, p=0.425 
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Table 15: Number of patients and controls with normal and abnormal absolute latency of 
wave III in the right ear and the differences 
 
 
 
Absolute 
latency of wave 
III,RIGHT EAR N Mean Std. Deviation Std. Error Mean 
Case 
30 3.5243 .13431 .02452 
Control 
30 3.6017 .19761 .03608 
 
t= - 1.733, p=0.082 
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Table 16: Number of patients and controls with normal and abnormal absolute latency of 
wave V in the right ear and the differences.  
 
 
Absolute latency 
of wave V ,right 
ear N Mean Std. Deviation 
Std. Error 
Mean 
Case 
30 5.3257 .22337 .04078 
Control 
30 5.4520 .25600 .04674 
 
t= - 2.03, p= 0.046 * 
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Table 17: Number of patients and controls with normal and abnormal absolute latency of 
wave I in the left ear and the diferences  
 
 
Absolute 
latency of 
wave I ,left ear N Mean Std. Deviation Std. Error Mean 
Case 
30 1.537 .1056 .0193 
Control 
30 1.538 .1315 .0240 
 
t= - 0.032, p= 0.974 
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Table 18: Number of patients and controls with normal and abnormal absolute latency of 
wave III  in the left ear and the differences.   
 
 
 
Absolute latency 
wave III, Left ear N Mean Std. Deviation Std. Error Mean 
Case 30 3.5600 .15779 .02881 
Control 30 3.6080 .18376 .03355 
t= - 1.085, p= 0.282 
Table 19: Number of patients and controls with normal and abnormal absolute latency of 
wave V in the left ear and the differences.  
 
 
 
Absolute 
latency wave 
V left ear N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Case 
30 5.3733 .20913 .03818 
Control 
30 5.4130 .24785 .04525 
 
t= - 0.670, p= 0.506 
 
 66 
 
Tables 20 to 25 show the number of patients with normal and abnormal BERA inter peak  
latencies of waves I- III, III-V and I-V   in the right ear and left ear  in patients and controls. 
The  difference in inter-peak  latencies of all the waves were not statistically significant 
 
 
 
 
 
 
Table 20: Number of patients and controls with normal and abnormal  inter peak  latencies of 
waves I- III, right  ear and the differences.  
 
Inter peak 
latency wave I-
III, right ear N Mean Std. Deviation Std. Error Mean 
Case 
30 1.9980 .11223 .02049 
Control 
30 2.0503 .13556 .02475 
t= - 1.629, p= 0.109 
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Table 21: Number of patients and controls with normal and abnormal inter peak latencies of 
waves III-V in right ear and the differences. 
  
 
Interpeak 
latency wave 
III-V, Right 
ear N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Case 
30 1.803 .1481 .0270 
Control 
30 1.845 .1238 .0226 
t= - 1.173, p= 0.24 
Table 22: Number of patients and controls with normal and abnormal inter peak latencies of 
waves I- V, right ear and the differences. 
 
Interpeak 
latencies wave 
I –V, Right ear N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Case 
30 3.8007 .18629 .03401 
Control 
30 3.8303 .37660 .06876 
t= - 0.387, p= 0.700 
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Table 23: Number of patients and controls with normal and abnormal   inter peak  latencies of 
waves I- III, left  ear and the differences.  
 
Interpeak 
latencies wave I 
To III, Left ear N Mean Std. Deviation 
Std. Error 
Mean 
Case 
30 2.0257 .11337 .02070 
Control 
30 2.0713 .10624 .01940 
t= - 1.610, p= 0.113 
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Table 24: Number of patients and controls with normal and abnormal  inter peak  latencies of 
waves  III-V, left  ear and the differences.  
 
Interpeak 
latencies 
wave III to V 
,Left ear N Mean Std. Deviation 
Std. Error 
Mean 
Case 
30 1.8087 .11548 .02108 
Control 
30 1.8063 .12907 .02356 
t=  0.074, p= 0.941 
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Table 25: Number of patients and controls with normal and abnormal inter peak latencies of 
waves I- V, left ear and the differences. 
 
 
 Interpeak 
latency wave I-
V, left ear N Mean Std. Deviation Std. Error Mean 
Case 
30 3.8310 .17639 .03220 
Control 
30 3.8720 .16890 .03084 
t=   - 0.920, p= 0.362 
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DISCUSSION 
 
 
This study was done in a tertiary care hospital to ascertain the frequency of migrainous vertigo  
by reviewing the charts of patients who visited the Audio vestibular clinic for various 
complains retrospectively over a period of 6 months and to evaluate the auditory status of 
diagnosed cases of Migrainous vertigo prospectively over a 6 month period. 
In the first part of the study which was a retrospective chart review,   the frequency of 
migrainous vertigo among the patients visiting the audio vestibular clinic was 20% (80/400), 
and of the patients presenting with vertigo the frequency of migrainous vertigo was 22.04% 
(80/363). Both these values are higher than that reported in literature (7%) (19). 
 
 The age group at which migrainous vertigo was most common, was  found to be between 31 to 
40 years(46/80) followed by 41 to 50 years(26/80). In literature migrainous vertigo can occur at 
any age group (6,7,19). The female to male ratio in our study was 1.22 is to 1 which is similar 
to that reported in Literature (6,7,19). 
A frequency of 27/80 (21%) patients were found to have documented evidence of hearing 
loss in  our chart review and this is far higher than that reported by Dash et al (8) which is 
3.5%.  He has however also noted that majority of the patients with migrainous vertigo have 
hearing loss that may be transient and non progressive (8). The type of hearing loss noted by 
us was mild as mentioned in his study. 
In the review of charts the age group at which hearing loss occurred maximum was found to be 
from 31 to 40 years (16/27). This could be due to the number of patients of migrainous vertigo 
were mostly in the same age group. 
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In the second part of the study, which was prospective with controls, of the 30 diagnosed with  
migrainous vertigo,  19 were females and 11 were males, the ratio being 1.73 which is similar 
to the ratio in literature (6,7,19). 
 Of the 30 patients, the maximum numbers of patients were seen in the age group 31-40 years 
as seen also in the retrospective case review carried out as first part of this study. Patients 
below 18 years were not included in the study as patients below this age usually attended 
paediatric ENT. Patients above 60 years were not included in the study to minimise the effect 
of other co-morbid conditions.  
In this study the duration of each attack of headache was most commonly found to be less than 
one hour (17/30), followed by 1-2 hours (12/30). According to literature the most common 
duration is also between 5-60minutes (33%) followed by 1-24 hours (21%). Thus the duration 
is similar to that given in literature (19). 
Thirty percent of patients in this study, experienced dizzy spells outside the period of headache, 
while in literature up to half (48%) can experience dizzy spells outside the period of headache 
(19).   
 
In this study, 30% of patients experienced positional vertigo, a little less than what we found in 
literature 42% (19). Motion sickness was found in 33% of patients and again less than what we 
found in literature 48% (19). Unsteadiness was experienced by 30% of patients and double 
vision by 17% of patients   in this study.  Dash et al have reported transient unsteadiness can 
occur in 16% of the patients with Migrainous vertigo (8).  
   
In migrainous vertigo, the most common vestibular symptom besides vertigo was  motion 
sickness (33%) followed by  positional vertigo (30%) which is similar to Neuhauser et al (19). 
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Auditory symptoms occurring in migrainous vertigo is considered less common than vestibular 
symptoms (18). In this study, tinnitus was experienced by 47% of patients as an aura during 
headache, while during the attack of migrainous vertigo, 53% of patients experienced auditory 
symptoms like hearing loss and tinnitus. Phonophobia was experienced by 43% of patients in 
our study.  
Thirteen percent of patients experienced hearing loss alone as an aura during the attack of 
headache. The most common auditory symptom in this study was hearing loss with tinnitus, 
(53%), followed by tinnitus alone (47%), phonophobia (43%) and hearing loss alone (13%). In 
the study by Dash et al (8), the most common auditory symptom was phonophobia (70%), 
followed by tinnitus (50%). This was in discordance with our study.  
In this study, 43% of patients experienced photophobia while in Neuhauser et al’s study (19), 
70% of patients experienced photophobia. Visual auras were experienced by all patients in our 
study while in Neuhauser et al’s study, 36% experienced visual auras and auras other than 
vertigo. Sometimes these may be the only symptoms the patients present with which could help 
link between vertigo and headache and should be specifically asked for. 
In our study 83% of patients had a positive family history of Migrainous headache. In literature 
it is mentioned that migraine and vertigo were found in familial hemiplegic migraine and 
episodic ataxia type 2 (35). However a susceptibility gene for the same has not yet been 
identified (36,37). 
In all 30 patients, aura was experienced within one hour of headache. At least one of the brain 
stem symptoms other than vertigo like unsteadiness,  zigzag lights in vision, darkness in 
vision and double vision, hearing loss and fullness of the ear, tinnitus was experienced by all 
the patients. This suggests that the commonest involvement in migrainous vertigo may be in 
the region of brainstem and posterior circulation territory of the brain.  
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The physical examination was normal in all 30 patients similar to what is known (7). 
Of the thirty patients who underwent a pure tone audiometry, 10 (33%) had documented mild 
sensory neural hearing loss. This value is much higher than that found in Dash’s study (8) 
which was is 14%.  11 patients had absent oto-acoustic emissions in either right or left ear. 
We found a larger proportion of patients (26 patients out of 30) had abnormal values in either 
absolute latency or inter-peak latency in one or both ears compared to the study by Dash et al 
(8). which had 7 out of 38 patients (18%) had documented evidence of mild sensory neural 
hearing loss. However in his study all patients had abnormalities in BERA intervals in either 
right or left ear.  
This prospective case controlled study conducted in a tertiary care specialised clinic showed a 
higher frequency of involvement of auditory pathway than what is reported in literature. From 
the battery of tests done it is suggestive that the involvement of the central auditory pathway 
may be earlier than the peripheral pathway as evidenced by abnormalities in BERA in all 
patients compared to PTA and DPOAE which were abnormal in 10 and 11 patients 
respectively. There is very little indication of involvement of middle ear function. A search of 
English literature revealed only one study which   highlights this aspect of migrainous vertigo. 
The use BERA testing in patients with migrainous vertigo would help to pick up early 
involvement of auditory pathway and these patients if started on prophylactic anti-migraine 
treatment could prevent progression of auditory involvement in this condition. 
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Limitations of the study 
This study was not powered to bring out differences between cases and controls for the various 
tests performed. A larger sample size may have provided results that were different. One reason 
for this smaller sample was the cost involved in recruiting more normal controls. The sample 
size is smaller than required. This was because of the cost factor involved in recruiting more 
normal controls. 
The matching of patients could have been closer than what was done. Often the recruitment had 
to depend on the availability of cases that fulfilled selection criteria and time.  
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CONCLUSIONS 
The frequency of migrainous vertigo in a tertiary care specialised audiovestibular clinic was 
22%. 
The largest age group attending tertiary care for this problem were in age group 31-40 (58%), 
The male: female ratio was 1:1.2. 
The frequency of hearing loss was 34% among 400 charts screened retrospectively. 
Symptoms pointing to posterior circulation territory involvement were present as an aura in all 
patients. 
33% percent of patients had documented bilateral mild sensory hearing loss. 
Tympanometry and stapedial reflex were normal in all patients 
There was significant difference between cases and control in the presence of distortion product 
otoacoustic emissions in both ears as well as in the absolute latency of wave V signifying the 
involvement of auditory pathway in migrainous vertigo.  
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1. PROFORMA FOR MIGRAINOUS VERTIGO 
 
Serial no- 
Name- 
Date- 
Hospital Number- 
Age- 
Sex- 
 
1)Are you or have you been subject to headache?        Yes             no  
2)Do your headaches come in more or less identical attacks?   Yes           no 
3)Are your headaches  
 a.at the front            yes            no 
 b.on both sides of your head       yes          no 
 c.at the back of your head           yes         no 
 d.in your neck                              yes         no 
4)how old were you when the headache started? 
5)how long does the headache last on an average? 
6)how often do you get headaches? 
7)do your headache have a throb any time during the attack.? 
8)do you have dizzy spells at other times than with your headache? 
9)are your dizzy spells related to position of your head? 
10)what are your headaches relieved by? 
11)have you ever had motion sickness? 
12)during or within an hour before your attack do you have any of the 
following complaints? 
  a.spots/shimmering/zigzag lights in your field of vision? 
  b.dark areas at the centre of your vision? 
  c.darkness in one half of your vision? 
  d.numbness or tingling around your mouth? 
  e.numbness or tingling over one half of your face or body? 
  f.weakness on one side /both sides of your face or body? 
  g.Difficulty in your speech? 
  h.dizziness? 
  i.unsteadiness? 
  j.double vision? 
  k.slurred speech? 
  l.noises in your ear? 
  m.hearing loss? 
  n.decreased level of conciousness/ 
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  o.blackouts? 
13)do you have any of the following complaints during your attacks 
  a.nausea 
  b.nausea and vomiting 
  c.increased sensitivity to bright lights. 
  d.increased sensitivity to loud sounds 
  e.disturbance with smell 
14)are your dizzy spells accompanied by noise in your ears or change in your 
hearing?                 Yes             no 
15)is there any family history of similar attacks? 
 
 
INVESTIGATIONS 
1) Pure Tone Audiogram                   Right ear                     Left ear 
 
   Air Conduction 
   Bone conduction 
2)Impedance                                      Right ear                     Left ear 
  
   Tympanometry 
   Stapedial reflux 
3) ABR                                                   Right ear                     Left ear 
   Absolute Latency 
         
   Wave 1 
    
   Wave 3 
    
   Wave 5 
    
 
 
Inter peak Latency 
Wave 1 and 3 
Wave 3 and 5 
Wave 1 and 5 
4)DPOAE                                             Right ear                     Left ear         
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                                   2.  INFORMED CONSENT DOCUMENT 
Study number- 
Participant’s name- 
Date of birth/age- 
 
I                            son/daughter/wife of                          give my consent to take 
part in this study.It has been explained to me that I will be tested for hearing 
problems that I may have due to my disease.All the tests done (four in 
number)are accected universally at the moment.Two of the four tests are a 
protocol for this condition.The two additional tests which will be done are not 
of any harm/risks to me.I understand that this is a clinical study done to know 
more about my disease and for its better treatment. 
                                                                It has been explained to me that I am free 
to withdraw from the study any time I want and will not in any way 
compromise the treatment ,the ENT department is giving me.I understand that 
my identity and participation will not be revealed in any information  released 
to third parties.I am giving this consent on my own free will.I have been 
explained about the study in a language familiar to me. 
 
Name                                           Signature                                                   Physician 
 
Name of relative(guardian/parent)                
Signature 
Name of witness 
Signature 
 
 
Signature of person taking consent. 
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slno idno name age sex diagnosis audiogram 
1 232098F YOMKEN BOKO 2 1 2 2 
2 232320F AJIT KUMAR 5 1 2 14 
3 23224F MAMTA PANDEY 2 2 1 2 
4 228414F MAYAKRISHNAN 1 2 2 0 
5 974661A SELVI 2 2 1 0 
6 229197F JAYAPRIYA 1 2 2 9 
7 233988F ROHIT DAS 1 1 3 12 
8 226766F MANIK DAS 4 1 2 2 
9 231909F KUSHBUL BEGUM 2 2 1 2 
10 239892F SELVARAJ 3 1 1 0 
11 223593F SUKDEV JANA 3 1 2 0 
12 225280F DURGA PRASAD 5 1 1 0 
13 181915F ABIMANYU 3 2 1 5 
14 225363F BASANA 3 1 2 1 
15 151392F JAYANTI 2 2 1 0 
16 232027F MATI DEVI 3 2 1 2 
17 230345F ROHIT MONDAL 0 1 2 0 
18 231252F SUNANDA BHUIN 0 2 3 8 
19 228304F 
SUPRATO 
MALAKAN 2 1 2 0 
20 151487F AMIT KUMAR CHAN 2 1 3 14 
21 229412F RADHA SHYAM 2 1 2 0 
22 215115F SOMNATH SINGH 2 1 2 0 
23 198045F DEBRUP SARKAR 1 1 3 12 
24 225611F DEEPAK 4 1 2 3 
25 232668F MANIKNATH 5 1 2 0 
26 209614F BRIJ KUMAR 3 1 2 0 
27 561221D MERCY INDRA 4 2 2 2 
28 027711B TAJUNEESA 4 2 2 2 
29 12307F SHADNAM KUMAR 1 1 3 12 
30 229306F VALLIAMMA 5 2 2 2 
31 219723F UGRENGRA KUMAR 5 1 2 0 
32 227663F LELIN.K 4 2 1 2 
33 229891F ARASU 3 1 2 0 
34 199124F MURUGESAN 3 1 2 14 
35 199426F ABDUL RASHHED 4 1 2 0 
36 233837F RAM SWARUP 1 1 2 0 
37 236491F RABEA BEGUM 4 2 2 0 
38 221511F GANGAMMA 5 2 3 13 
39 72566A LLOGANAYAGI 5 2 2 0 
40 233970F DIBANKER MONDAL 3 1 2 0 
41 019517F SRIDHAR 3 1 2 0 
42 228304F 
SUPRANATH 
MALAK 3 1 1 0 
43 222958F NARASIMHAN 4 1 2 2 
44 189481C VINAYAN 3 1 2 2 
45 962305D LEELAVATHYSBABY 0 2 3 12 
46 871145A SHYAMALA 5 1 3 2 
47 229649F MUNIYAN 3 1 1 0 
48 772094D BARNALI NANDY 3 2 2 3 
49 219347F CHINNDRA 3 2 1 0 
50 905415C SHAMEEM 3 1 2 0 
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51 037430C JAISHANKER 3 1 2 0 
52 228713F MADHABI DAS 2 2 3 2 
53 788773C RAJAN 5 1 2 8 
54 477587C PARUL DEY 3 1 2 1 
55 671597D RAM KALLESHWAR 3 1 2 2 
56 283907 RICHARD 5 1 2 6 
57 983854C BIRU KUMAR 1 1 3 12 
58 229891F ARASU SK 3 1 2 0 
59 216616F SUBENDRA DEB 3 1 3 14 
60 905415C SHAMEEM 1 1 2 0 
61 037430F JAISHANKER 2 1 2 0 
62 940692D BIDHAN ROY 4 1 2 7 
63 895891D SUJATHA 2 2 1 2 
64 972800D VIJI 3 2 2 0 
65 963340D PRATIMA PAUL 3 2 2 10 
66 817795D NEHA TAGE 2 2 2 0 
67 232906F SELVI 1 2 2 14 
68 239889F RAJESH PRADHAN 2 1 1 2 
69 174616F DASARADHAN 3 1 2 0 
70 247326F TULSI SUBBA 3 2 2 0 
71 730810A SRINIVASAN 4 1 2 0 
72 248376F ROSIA BIBI 3 2 2 7 
73 237080F RAJA SAHEB 1 1 2 1 
74 247264f BUDD SAHA 4 1 2 3 
75 255434F KACHALA MADHU 1 2 1 0 
76 247172F VICTORIA 4 2 2 9 
77 166328F YUVARAJULU 5 1 2 2 
78 198398F SEEMA BERA 2 2 2 2 
79 251788f TUSHAR KANTI 2 1 2 4 
80 862447B ALAMELU 4 1 2 0 
81 364795B THIRUMAGAL 1 2 1 0 
82 856219 ANNAMALAI 5 1 2 0 
83 078050C SHENBAKAVALLI 3 2 1 2 
84 841681B SARALA 2 2 2 0 
85 117181F JANCE G 4 2 2 0 
86 224512F RAMASAMY 5 1 2 4 
87 189481C VINAYAGAM 5 1 2 4 
88 287373 JESSIE EDWARD 5 2 2 0 
89 233988F ROHIT DAS 4 1 3 10 
90 233858F DATTARAM 4 1 2 5 
91 332692F PRADIP SARKAR 3 1 2 2 
92 232027F MALTI DEVI 3 2 1 4 
93 222958F NARASIMHAN 3 1 2 4 
94 233175F GOURI DAS 3 2 2 0 
95 236295F LATHA S 2 2 1 0 
96 946929D RABINDRA KUMAR 3 1 2 0 
97 956315D SNEHADRI PACHEL 3 2 2 5 
98 237251F RAJENDER PANDIT 3 1 2 0 
99 213234F KANAHASABHAI 4 1 2 6 
100 238887F PUNANJAY KUMAR 2 1 2 2 
101 238443f ASGAR SABA 4 1 2 2 
102 238982F PRASHANT KUMAR 3 1 2 2 
103 166330F RAM CHANDRA 4 1 2 2 
104 237877F ASHWIN R 2 1 2 0 
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105 249402F JAI MUNNA DEV 3 1 2 2 
106 174616F DASARADHAN 3 2 2 0 
107 244043F INDU CHAKRABORT 2 2 1 0 
108 130837A AMRITA DAS 2 2 2 2 
109 084727A SELVAKUMAR 2 1 1 0 
110 088991F SABITA DAS 2 2 2 4 
111 730810A AJ JOSEPH 3 1 2 0 
112 964299D 
PRAJENDRA 
CHAND 2 1 1 2 
113 778053c NATARAJAN 4 1 2 0 
114 134307F FAZALUR RAHMAN 2 1 1 14 
115 244016F SRILAKHSMI 3 2 2 0 
116 241385F UTPAL BISWAS 1 1 2 0 
117 189604F SELVI 2 2 1 2 
118 166328F YUVRAJULUU 5 1 2 4 
119 101017F RAJAMANI 3 2 3 8 
120 219296F GEETA SINGH 2 2 2 0 
121 242471F SANTHOSH KUMAR 3 1 2 2 
122 244070F KASHI NATH 3 1 2 2 
123 233428F MINA CHATTARAJ 4 2 2 0 
124 242699F BENU BALA 5 2 2 2 
125 122018F PUNITHA R 1 2 3 10 
126 244043F INDU CHAKRABORT 1 2 1 0 
127 231562F SANKAR DEY 3 1 2 0 
128 232906F SELVI 1 2 2 14 
129 239889F RAJESH PRADHAN 3 1 1 2 
130 174616F DASARADHAN 3 1 2 0 
131 247326F TULSI SUBBA 3 1 2 0 
132 230810A KUMAR 2 1 2 0 
133 267737F SUSHAR BAHAT 2 1 2 0 
134 252888F VISVANADAN 2 1 3 2 
135 073886F GAURAV KUMAR 1 1 3 0 
136 261622F PARVATHI 1 2 2 0 
137 121355F JHUNI PANIGRAHI 2 2 1 0 
138 270976F JOYDEB BISWAS 2 1 2 4 
139 273289F DIPAK SAMLAL 2 1 2 2 
140 270379F RUBIN DAS 3 1 2 0 
141 276330F RANJIT MUKHERJE 3 1 1 0 
142 270434F LAKHI MONDAL 2 2 1 0 
143 271665F INDARDEO 3 1 2 0 
144 272428F NEELAM JAISWAL 2 2 2 0 
145 270300f MINATI MAITI 3 2 3 2 
146 273352F SHUNI RATHI 2 1 3 9 
147 272821F MANOHAR SHIL 3 1 2 4 
148 265070C NIRMALA 3 2 2 0 
149 235967F DHRUBA LAL 4 1 2 0 
150 169794F RAJA 2 1 1 0 
151 263994F KAMLIDASS 3 2 2 7 
152 188150F TUTUL DEBNATH 1 2 3 11 
153 114958F NANDA BHUNIA 1 2 3 11 
154 270991F SAHEDA MAHELI 3 2 2 2 
155 266099F NANDAKUMAR 3 1 2 0 
156 248574f JALAJAKSHI 2 2 2 2 
157 272492F PINTU GUPTA 3 2 2 0 
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158 275354F LAKHSMI 4 2 2 4 
159 268749F SHIRU SULTHANA 2 1 1 2 
160 256433F SUSHILA J 2 2 1 2 
161 273352F SHUNI RATHORE 4 2 3 4 
162 241732F NIBEDITA BISMI 1 2 3 12 
163 247952F ARVIND KUMAR 2 1 1 0 
164 258460F KUMKUM DEVI 3 2 1 13 
165 364795B THIRUMAGAL 2 1 1 0 
166 261209F CHANDRA NATH RA 3 1 2 0 
167 268955F SANJEEVI 3 2 1 0 
168 270300F MINATI MAITI 5 2 3 2 
169 272021F MANOHAR SHIL 2 1 2 14 
170 270976F JOYDEB BISWAS 3 1 2 4 
171 266307F MALTI DEVI 3 2 2 0 
172 270379F RUBI DAS 3 2 2 0 
173 264590F BISHNUPRIYA 2 2 2 3 
174 271924F UMAR 1 1 2 0 
175 263120F DIP MONDAL 0 1 3 10 
176 263122F RASHI MONDAL 1 2 3 12 
177 239357F RAJU NT 5 1 2 6 
178 245869F MANI 3 1 2 0 
179 268360F GANESAN 4 1 2 0 
180 270434F LAKHI MONDAL 2 2 1 0 
181 272033F GOURANGA MAITY 3 1 1 1 
182 244744F KOUSHIK NAIYA 4 1 2 6 
183 140803F ARJUN VISVA KAR 3 1 2 4 
184 263994F KAMLI DEVI 3 2 2 7 
185 250259F DRUBHA LAL 3 1 2 2 
186 244752F KULDEEP 3 1 2 0 
187 233124F PARBATI GHOSH 3 2 2 2 
188 261188F MRIND KANTI 3 1 2 3 
189 236018F ANJU SINHA 2 2 1 0 
190 219834F ALAKRAJ DUTTA 4 1 2 14 
191 268005F EVERGREEN SHYLL 1 2 2 2 
192 265788F LALITHA DEVI 2 2 1 2 
193 272197F PRAKASH SINGH 5 1 2 1 
194 057615F TAMALIKA 2 2 2 0 
195 263360F PRABIR BARUAH 3 1 2 0 
196 273706F JAYARAMAN 1 1 3 0 
197 246619F NARESH KUMAR 0 1 1 0 
198 263277F BABU 3 1 2 5 
199 266521F DEVI 2 2 1 0 
200 250325F VIJAYA 2 2 1 2 
201 199860F PRABHA DEVI 3 2 1 0 
202 268817F AMIT KUMAR 2 1 2 9 
203 267867F RAM VISVAKARMA 2 1 3 2 
204 265967F SWAPAN DEY 5 1 2 2 
205 268655f RAKESH KUMAR 4 1 2 8 
206 143730F ARUN MONDAL 1 1 3 12 
207 271082F DEETIPATRA 0 2 1 0 
208 204321F ARUN KUMAR 1 1 3 11 
209 260583F ROSALINE 3 2 2 0 
210 264347F KSHETRI MAYAN 3 1 2 0 
211 131978F TASHI BHUTIA 1 1 3 12 
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212 260075F ASIM BAG 3 1 1 2 
213 082515F MAYA DAS 3 2 1 2 
214 731306D PAPPU KUMAR 4 1 2 0 
215 262778F PREMA DEVI MODI 2 2 1 2 
216 258028F MON SAHA 5 1 2 0 
217 268187F KALIPADA SARKAR 2 1 2 14 
218 155158F NIZAMUL HAQUE 2 1 1 0 
219 256585F SARASWATI 4 2 2 5 
220 266099F NANDAKUMAR 4 1 2 8 
221 248830F NANDA 2 2 1 2 
222 270508F SANGITA DEBI 2 2 1 0 
223 264590F BISHNUPRIYA 2 2 2 3 
224 267737F SUBHAS BHAKAT 3 1 2 2 
225 261437F MUBIYA 2 2 2 2 
226 253704F NIBARAM CHANDRA 3 1 2 3 
227 127274F RANGASAMY 4 1 2 0 
228 258460F KUMKUM DEVI 3 2 2 13 
229 304628D VENKATESAN 2 1 2 0 
230 249709F SWETA KARMAKAR 1 2 3 12 
231 262420F CHARANJEDI 3 1 2 4 
232 262217F ZAKIR HUSSAIN 4 1 2 0 
233 266521F DEVI N 2 2 1 2 
234 242533F ASHOK YADAV 4 1 2 9 
235 131978F TASHI DHUNDUP 2 1 3 11 
236 253704F NIBARBAN MONDAL 3 1 2 3 
237 258767F ARUP BATABEL 2 1 2 11 
238 260575F RABANI ADITYA 2 1 2 1 
239 260922F AMIT MAITY 3 1 2 0 
240 305892F HARADHAN SAHA 3 1 2 8 
241 188902F SHYAM SUNDER 2 1 2 3 
242 303304F DILIP SINGH 4 1 2 7 
243 703297F VIJAYA R 2 2 1 2 
244 306439F PINTU DEBNATH 2 2 2 4 
245 302706F BIMAL KUMAR 2 1 1 0 
246 301264F ABHIJIT SADU 2 1 1 0 
247 304126f AKBAR ALAM 2 1 2 7 
248 298795F LATHA 3 2 2 0 
249 107230f HARADHAN PAUL 3 1 2 4 
250 111677F SUBRATA GHOSH 3 1 2 0 
251 276784f RAM PRASAD 2 1 2 5 
252 288036F SOMA DUTTA 3 2 2 0 
253 288392F KRISHNA KANTA 2 1 2 1 
254 300007F SYED NAZIRUDDIN 3 1 2 0 
255 307201F ALOK KUMAR 4 1 2 0 
256 950425B PARTHSARTHY 5 1 2 0 
257 185681F RAJENDRAN 3 1 2 2 
258 292116F SUBHADEEP DEY 2 1 1 0 
259 023767B TARA SAMUEL 4 2 2 4 
260 538499B SWAPNA 3 2 1 0 
261 300945F SUSANG LEPCHA 1 2 3 12 
262 279607F RADHA SHYAM 1 1 3 10 
263 212307F SHADNAM KHAMAR 1 1 2 3 
264 303945F SADHAN KUMAR DE 2 1 3 9 
265 303934F GAYATHRI DEVI 3 2 2 8 
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266 284129F JHARNA MONDAL 2 2 2 13 
267 258786F SUNIL KUMAR 4 1 2 7 
268 297624F NEMAI MONDAL 2 1 2 7 
269 537511D JOSEPH 5 1 2 0 
270 302226F PRAITY JAEL 2 1 1 0 
271 303910F KAKALI 2 2 2 11 
272 249175F RAYALAMMAL 4 2 2 0 
273 147823F NANDAKUMAR 2 1 2 10 
274 291254F JOHN KENNEDY 3 1 2 10 
275 283791F PUTUL SHIL 2 1 2 0 
276 305666F APARESH BANERJE 2 1 2 12 
277 301444F PRATIMA MIDYA 3 2 2 0 
278 281229F GURUSAMY 2 1 2 2 
279 303752F SIKDAR 4 1 2 0 
280 291771F RAJAVELI 3 1 2 0 
281 251539F JAISHANKER 5 1 2 0 
282 242405F ANWAR BASHA 3 1 2 0 
283 295934F ROSE MARY 4 2 2 0 
284 294507F TAPAS DUTTA 3 1 2 0 
285 071446A VIMALA RAM 5 2 2 4 
286 307762F KANNIYAMMAL 2 2 1 0 
287 368777A SUSEELA 4 2 2 2 
288 111517F SULTHAN B 3 1 2 2 
289 144788F GOUTAM GHOSH 3 1 2 3 
290 300034F SANJAY KUMAR 4 1 2 8 
291 302260F DULAL DEBNATH 3 1 2 0 
292 296442F PUSHPA SINGH 3 2 2 0 
293 305546F 
SURENDRA 
PRASAD 3 1 2 2 
294 302748F ARCHANA SINGHA 2 2 2 0 
295 300942F RABINDRA SARKAR 2 1 2 11 
296 290486F SHAKUNTHALA 2 2 2 0 
297 294851F ATWARI RANA 3 1 2 0 
298 301583F MEBANJOP 2 2 2 0 
299 964940F AINUL HAQUE 4 1 2 0 
300 305570F SATYABAMA 4 2 2 4 
301 285208B MURALIDHARAN 5 1 2 0 
302 197218F BHAKTI PRASAD 2 1 2 12 
303 144255F CHANDRASHEKAR 2 1 2 12 
304 258669F MANISHA RAY 3 2 1 2 
305 296442f PUSHPA SINGH 2 2 2 0 
306 083465F ABIRAMI 0 2 3 10 
307 772629D SWAPAN SEN 3 1 2 5 
308 709190C ZAMRUTH BEE 3 2 2 0 
309 311771F NAYAN DUTTA 2 1 1 2 
310 312133F SUSIT CHAKRABOR 4 1 2 0 
311 144788F GOUTAM GHOSH 1 1 2 0 
312 479698 SHANMUGAM 4 1 2 12 
313 183656F RAMAKRISHNAN 4 1 2 2 
314 243115C RAJENDRA REDDY 3 1 1 0 
315 588587D MANIVELU 4 1 2 9 
316 302260F DULAL DEBNATH 4 1 2 0 
317 241436F ARCHANA BASUALI 3 2 2 0 
318 299869F ASHISH KUMAR 3 1 2 3 
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319 310288F CHARU BALA DEVI 3 2 2 0 
320 185681f RAJENDRA 3 1 2 1 
321 315989F KIRAN DEVI 3 2 2 11 
322 797313B SHAKTHIVEL 3 1 1 2 
323 252985F SRINIVASAN 2 1 1 0 
324 256433F SUSHILA 4 2 2 5 
325 305952F PRABIR BARUA 2 1 2 0 
326 312121F SWAPAN KUMAR 2 1 2 0 
327 879723C LEELAVATHY 4 2 2 7 
328 302271F ROSALINE 3 2 2 0 
329 104061F SHYAMA MONDAL 3 2 1 0 
330 305892F HARADHAN SAHA 3 1 2 8 
331 315937F DEBJIT GHORUI 2 1 2 0 
332 292110D JAI PRAKASH 3 1 2 0 
333 311250F SWETHA DUTTA 2 2 1 0 
334 291220f BHAKTHI PRASAD 3 1 2 11 
335 311122F KRISH BANI 2 1 2 0 
336 312465F BIRENDRA NATH 4 1 2 0 
337 327094F MINCHI ADHIKARI 3 2 2 0 
338 307201F ALOK MUKERJEE 3 1 2 3 
339 313360F MATIUR RAHMAN 3 1 2 0 
340 298810F RUBI NANDI 2 2 2 0 
341 290489F LAKSMI RANI DUT 3 2 2 8 
342 305783F AJAY SARKAR 2 1 1 2 
343 144560F SUDHAM MAIHAP 3 1 2 4 
344 298803F ANURADH KUMAR 4 1 2 10 
345 273741F BHOLANATH SAHU 5 2 2 9 
346 169559D NEELAM SINGH 2 2 2 2 
347 325871B IRUCHAPPAN 5 1 2 4 
348 503658F VASANTHA 2 2 2 7 
349 655824B MANIVANNAN 3 1 2 2 
350 312024F PAIPAYA ACHARYA 2 1 1 0 
351 315963F RAJENDRAN 3 1 2 11 
352 640186B SUBRAMANI 3 1 2 14 
353 981973B DROPADICHANDELI 2 2 2 0 
354 812940B SRIMATHI R 3 2 2 0 
355 330199 GOVINDAMMA 4 2 2 2 
356 148651F PREMA S 3 2 2 0 
357 313124F MAHMUDA KHATUN 2 2 2 12 
358 751602D CHITTIAMMA 3 2 2 0 
359 320237F GOLAM MUSTAFA 3 1 2 0 
360 183656F RAMAKRISHNAN 3 1 2 2 
361 299509F BISHAK BERA 1 1 2 0 
362 956575D LAKSMI M 2 2 2 2 
363 302533D SHAKEEL BASHA 3 1 2 3 
364 399595D RABINDRA SINGH 3 1 2 0 
365 315304F ILA BISWAS 2 2 2 8 
366 170737F 
AMALENDU 
PANDEY 3 1 1 0 
367 274883B JANAKI 5 2 2 4 
368 312566F VINCENT JOHN 3 1 1 2 
369 312933F SWAPAN SARKAR 3 1 1 0 
370 299000F KHAGENDRANATH 5 1 2 4 
371 303592F PRASHANT KUMAR 2 1 2 10 
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372 297072F RABINDRA DHALI 3 1 1 0 
373 310537F LINDA SUSANNE 2 2 1 0 
374 273334F MOUMITA BANERJI 2 2 2 10 
375 503966D LIMY MATHEW 1 2 1 2 
376 851479D SANJIB GHOSH 4 1 2 9 
377 315805F SHASHI CHANDAN 3 1 2 2 
378 252842F ANWAR BASHA 2 1 2 2 
379 409648A VIJAY KUMAR 2 1 1 0 
380 674276C FAIROON 2 2 2 0 
381 279604F DIPANKER MONDAL 0 1 3 0 
382 262446F ABHISHEK B 2 1 2 0 
383 312465F BIRENDRA NATH 3 1 1 0 
384 675810C LAKSMI KANTA 3 1 2 0 
385 286407F FESTING 4 1 2 2 
386 310526F MANIK SUTRADHAR 4 1 2 0 
387 312933F SWAPNA SARKAR 2 2 2 0 
388 301036F SOMNATH DEY 2 1 1 0 
389 247474F RANJIT BHOUMIK 4 1 2 4 
390 310797F BASANTI DEVI 3 2 2 0 
391 312388F PADMA MOHAN 3 1 2 0 
392 310681F MINA PATEL 2 2 2 14 
393 308931F KHAILAS NATH 4 1 2 7 
394 178853F AJITHA 2 2 1 0 
395 239533F DAMODHAR DAS 4 1 2 14 
396 254823F SURESH BABU 2 1 1 0 
397 328754f LATHA 2 2 1 0 
398 326346F ANIL KUMAR 4 
 
2 1 
399 761795D DEBI PRASAD 4 1 2 0 
400 615058D BRINDA DEVI 5 2 2 4 
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